Document:

Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT 

 

This SECURITIES
PURCHASE AGREEMENT (this “Agreement”) is dated as of January 28, 2015, by and among AMERIS BANCORP,
a corporation organized under the laws of Georgia (the “Company”), and each purchaser identified on the signature
pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

 

RECITALS 

 

WHEREAS, the
Company and each Purchaser are executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 of
Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the “Commission”)
under the Securities Act;

 

WHEREAS, each
Purchaser, severally and not jointly, wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated
in this Agreement, that aggregate number of shares of the Company’s common stock, $1.00 par value per share (the “Common
Stock”), set forth below such Purchaser’s name on the signature page of this Agreement (which aggregate amount
for all Purchasers together shall be 5,320,000 shares of Common Stock (the “Common Stock” or the “Common
Shares”);

 

WHEREAS, the
Company has engaged Sandler O’Neill & Partners, L.P. as its placement agent (the “Placement Agent”)
for the offering of the Common Shares; and

 

WHEREAS, contemporaneously
with the execution and delivery of this Agreement, the parties hereto are executing and delivering a Registration Rights Agreement,
substantially in the form attached hereto as Exhibit A (the “Registration Rights Agreement”), pursuant
to which, among other things, the Company will agree to provide certain registration rights with respect to the Common Shares under
the Securities Act and the rules and regulations promulgated thereunder and applicable state securities laws;

 

NOW, THEREFORE,
in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, the Company and the Purchasers hereby agree as follows:

 

ARTICLE
1

DEFINITIONS

 

1.1           Definitions.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement the following terms shall have
the meanings indicated in this Section 1.1:

 

“Action”
means any action, suit, inquiry, notice of violation, proceeding (including any partial proceeding such as a deposition) or investigation
pending or, to the Company’s Knowledge, threatened in writing against the Company, any Subsidiary or any of their respective
properties or any officer, director or employee of the Company or any Subsidiary acting in his or her capacity as an officer, director
or employee before or by any federal, state, county, local or foreign court, arbitrator, governmental or administrative agency,
regulatory authority, stock market, stock exchange or trading facility.

 

    	 

    	 

    

 

“Affiliate”
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, Controls,
is controlled by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the
Securities Act.

 

“Agreement”
shall have the meaning ascribed to such term in the Preamble.

 

“Bank”
has the meaning set forth in Section 3.1(a).

 

“BHCA”
has the meaning set forth in Section 3.1(b).

 

“Business
Day” means a day, other than a Saturday or Sunday, on which banks in New York City are open for the general transaction
of business.

 

“CIBCA”
has the meaning set forth in Section 3.2(q).

 

“Closing”
has the meaning set forth in Section 2.1(c)(i).

 

“Closing Date”
means January 28, 2015, or such other date as the parties may agree.

 

“Code”
means the Internal Revenue Code of 1986, as amended, including the regulations and published interpretations thereunder.

 

“Commission”
has the meaning set forth in the Recitals.

 

“Common Shares”
has the meaning set forth in the Recitals.

 

“Common Stock”
has the meaning set forth in the Recitals, and also includes any securities into which the Common Stock may hereafter be reclassified
or changed.

 

“Company Deliverables”
has the meaning set forth in Section 2.2(a).

 

“Company Counsel”
means Rogers & Hardin LLP.

 

“Company Reports”
has the meaning set forth in Section 3.1(jj).

 

“Company’s
Knowledge” means with respect to any statement made to the knowledge of the Company, that the statement is based upon
the actual knowledge of the executive officers of the Company having responsibility for the matter or matters that are the subject
of the statement after reasonable investigation.

 

“Control”
(including the terms “controlling”, “controlled by” or “under common control with”) means the
possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether
through the ownership of voting securities, by contract or otherwise.

 

“Disqualification
Event” has the meaning set forth in Section 3.1(tt)(i).

 

    	2

    	 

    

 

“DTC”
means The Depository Trust Company.

 

“Environmental
Laws” has the meaning set forth in Section 3.1(l).

 

“ERISA”
means the Employee Retirement Income Security Act of 1974, as amended, including the regulations and published interpretations
thereunder.

 

“ERISA Affiliate”,
as applied to the Company, means any Person under common control with the Company, who together with the Company, is treated as
a single employer within the meaning of Section 414(b), (c), (m) or (o) of the Code.

 

“ERISA Entity”
means any of (i) an “employee benefit plan” within the meaning of Section 3(3) of ERISA subject to Title I of ERISA,
(ii) a “plan” within the meaning of Section 4975(e)(1) of the Code and (iii) any Person whose assets are deemed to
be “plan assets” within the meaning of ERISA Section 3(42) and 29 C.F.R. § 2510.3-101 or otherwise under ERISA.

 

“Escrow Agent”
has the meaning set forth in Section 2.1(b).

 

“Escrow Agreement”
has the meaning set forth in Section 2.1(b).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations promulgated
thereunder.

 

“FDIC”
means the Federal Deposit Insurance Corporation.

 

“FRB”
means the Board of Governors of the Federal Reserve System.

 

“GAAP”
means U.S. generally accepted accounting principles, as applied by the Company.

 

“GDBF”
means the Georgia Department of Banking and Finance.

 

“Georgia Courts”
has the meaning set forth in Section 6.8.

 

“Hazardous
Materials” has the meaning set forth in Section 3.1(l).

 

“Indemnified
Person” has the meaning set forth in Section 4.8(a).

 

“Intellectual
Property” has the meaning set forth in Section 3.1(r).

 

“Issuer Covered
Person” has the meaning set forth in Section 3.1(tt)(i).

 

“Legend Removal
Date” has the meaning set forth in Section 4.1(c).

 

“Lien”
means any lien, charge, claim, encumbrance, security interest, right of first refusal, preemptive right or other restrictions of
any kind.

 

“Losses”
has the meaning set forth in Section 4.8(a).

 

    	3

    	 

    

 

“Material
Adverse Effect” means any of (i) a material and adverse effect on the legality, validity or enforceability of this Agreement,
the Registration Rights Agreement or the Escrow Agreement, (ii) a material and adverse effect on the results of operations, assets,
properties, business or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) any
adverse impairment to the Company’s ability to perform in any material respect on a timely basis its obligations under this
Agreement, the Registration Rights Agreement or the Escrow Agreement; provided, however, that in determining whether
a Material Adverse Effect has occurred, there shall be excluded any effect to the extent resulting from the following: (A) changes,
after the date hereof, in GAAP or regulatory accounting principles generally applicable to banks, savings associations or their
holding companies; (B) changes, after the date hereof, in applicable laws, rules and regulations or interpretations thereof by
any court, administrative agency or other governmental authority, whether federal, state, local or foreign, or any applicable industry
self-regulatory organization; (C) actions or omissions of the Company expressly required by the terms of this Agreement or taken
with the prior written consent of an affected Purchaser; (D) changes, after the date hereof, in general economic, monetary or financial
conditions; (E) changes in the market price or trading volumes of the Common Stock (but not the underlying causes of such changes);
(F) changes in global or national political conditions, including the outbreak or escalation of war or acts of terrorism; and (G)
the public disclosure of this Agreement or the transactions contemplated hereby, except, with respect to the immediately preceding
clauses (A), (B), (D) and (F), to the extent that the effects of such changes have a disproportionate effect on the Company and
the Subsidiaries, taken as a whole, relative to other similarly situated banks, savings associations or their holding companies
generally.

 

“Material
Contract” means any contract of the Company that was, or was required to be, filed as an exhibit to the SEC Reports pursuant
to Item 601 of Regulation S-K.

 

“Money Laundering
Laws” has the meaning set forth in Section 3.1(ii).

 

“Multiemployer
Plan” means a “multiemployer plan” as defined in Section 4001(a)(3) of ERISA to which the Company or any
ERISA Affiliate is making, or is accruing an obligation to make, contributions or has made, or been obligated to make, contributions
within the preceding six (6) years.

 

“NASDAQ”
means the NASDAQ Global Select Market.

 

“OFAC”
has the meaning set forth in Section 3.1(hh).

 

“Outside Date”
means February 13, 2015.

 

“Pension Plan”
means any employee pension benefit plan within the meaning of Section 3(2) of ERISA, other than a Multiemployer Plan, which is
subject to the provisions of Title IV of ERISA or Section 412 of the Code or Section 302 of ERISA and which (i) is maintained for
employees of the Company or any of its ERISA Affiliates or (ii) has at any time during the last six (6) years been maintained for
the employees of the Company or any current or former ERISA Affiliate.

 

    	4

    	 

    

 

“Person”
means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock company,
joint venture, sole proprietorship, unincorporated organization or governmental authority.

 

“Placement
Agent” has the meaning set forth in the Recitals.

 

“Placement
Agent Covered Person” has the meaning set forth in Section 3.1(tt)(ii).

 

“Potential
Company Acquisitions” has the meaning set forth in Section 3.2(t).

 

“Press Release”
has the meaning set forth in Section 4.6.

 

“Principal
Trading Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading, which,
as of the date of this Agreement and the Closing Date, shall be the NASDAQ.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition).

 

“Purchase
Price” means $22.50 per Common Share.

 

“Purchaser
Deliverables” has the meaning set forth in Section 2.2(b).

 

“Registration
Rights Agreement” has the meaning set forth in the Recitals.

 

“Registration
Statement” means a registration statement meeting the requirements set forth in the Registration Rights Agreement and
covering the resale by the Purchasers of the Registrable Securities (as defined in the Registration Rights Agreement).

 

“Regulation
D” has the meaning set forth in the Recitals.

 

“Required
Approvals” has the meaning set forth in Section 3.1(e).

 

“Rule 144”
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“SEC Reports”
has the meaning set forth in Section 3.1(h).

 

“Secretary’s
Certificate” has the meaning set forth in Section 2.2(a)(vi).

 

“Securities
Act” has the meaning set forth in the Recitals.

 

“Stock Certificates”
has the meaning set forth in Section 2.1(b).

 

“Subscription
Amount” means with respect to each Purchaser, the aggregate amount to be paid for the Common Shares purchased hereunder
as indicated on such Purchaser’s signature page to this Agreement next to the heading “Aggregate Purchase Price (Subscription
Amount)”.

 

    	5

    	 

    

 

“Subsidiary”
means any entity in which the Company, directly or indirectly, owns sufficient capital stock or holds a sufficient equity or similar
interest such that it is consolidated with the Company in the financial statements of the Company.

 

“Trading Day”
means (i) a day on which the Common Stock is listed or quoted and traded on its Principal Trading Market or (ii) if the Common
Stock is not listed or quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as
reported in the “pink sheets” by OTC Markets Group Inc. (or any similar organization or agency succeeding to its functions
of reporting prices); provided, however, that in the event that the Common Stock is not listed or quoted as set forth
in (i) and (ii) hereof, then Trading Day shall mean a Business Day.

 

“Trading Market”
means whichever of the NYSE, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market
or the OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question.

 

“Transaction
Documents” means this Agreement, the Exhibits attached hereto, the Registration Rights Agreement, the Escrow Agreement
and any other documents or agreements executed in connection with the transactions contemplated hereunder.

 

“Transfer
Agent” means Computershare Investor Services, or any successor transfer agent for the Company.

 

“Treasury”
means the United States Department of the Treasury.

 

“U.S. Sanctions
Laws” has the meaning set forth in Section 3.2(r).

 

ARTICLE
2

PURCHASE AND SALE

 

2.1         Closing.

 

(a)          Purchase
of Common Shares. Subject to the terms and conditions set forth in this Agreement, at the Closing the Company shall issue
and sell to each Purchaser, and each Purchaser shall, severally and not jointly, purchase from the Company, the number of Common
Shares set forth below such Purchaser’s name on the signature page of this Agreement at a per Common Share price equal to
the Purchase Price. Notwithstanding the foregoing, no Purchaser shall be obligated to purchase, and the Company shall not be obligated
to sell to any such Purchaser, any Common Shares to the extent such purchase would result in such Purchaser (together with such
Purchaser’s affiliates (as such term is used in the BHCA)) becoming, directly or indirectly, the owner for purposes of the
BHCA and the CIBCA of more than 9.9% of the number of shares of Common Stock issued and outstanding.

 

(b)          Escrow.
On or prior to 10:00 a.m. New York City time on the Closing Date, (i) each Purchaser shall have deposited the Subscription Amount
with SunTrust Bank as Escrow Agent (the “Escrow Agent”), pursuant to that certain Escrow Agreement (in the form
attached hereto as Exhibit F) between the Company and the Escrow Agent (as it may be amended or otherwise modified from
time to time, the “Escrow Agreement”), and (ii) the Company shall have issued instructions to the Transfer Agent
authorizing the issuance in certificated form of the number of Common Shares specified on such Purchaser’s signature page
hereto (the “Stock Certificates”), or as otherwise set forth on the Stock Certificate Questionnaire included
as Exhibit B-2 hereto, concurrent with the Escrow Agent’s release of the Subscription Amount to the Company pursuant
to the Escrow Agreement.

 

    	6

    	 

    

 

(c)        Closing
Date.

 

(i)          The
Closing of the purchase and sale of the Common Shares shall take place at 10:00 a.m., New York City time, at the offices of Company
Counsel, on the Closing Date or remotely by facsimile transmission or other electronic means or at such other time or location
as the parties may mutually agree, but not later than the Outside Date. The “Closing” means the release of funds
and issuance by the Company of Common Shares as contemplated hereby, all of which shall be deemed to have happened concurrently.

 

(ii)         On
the Closing Date, the Escrow Agent shall release the Subscription Amount to the Company pursuant to the terms of the Escrow Agreement
and the Transfer Agent shall issue the Common Shares to each Purchaser as provided in the instructions referred to in Section 2.1(b).

 

2.2         Closing
Deliveries.

 

(a)          On
or prior to the Closing, the Company shall issue, deliver or cause to be delivered to each Purchaser (unless otherwise indicated)
the following (the “Company Deliverables”):

 

(i)          this
Agreement, duly executed by the Company;

 

(ii)         Stock
Certificates for the Common Shares subscribed for by such Purchaser, which the Company shall cause the Transfer Agent to issue;

 

(iii)        a
legal opinion of Company Counsel, dated as of the Closing Date and in the form attached hereto as Exhibit C, executed by
such counsel and addressed to the Purchasers;

 

(iv)        the
Registration Rights Agreement, duly executed by the Company (which shall be delivered on the date hereof);

 

(v)         the
Escrow Agreement duly executed by the Company and the Escrow Agent (which shall be delivered on the date hereof);

 

(vi)        a
certificate of the Secretary of the Company, in the form attached hereto as Exhibit D (the “Secretary’s Certificate”),
dated as of the Closing Date, (A) certifying the resolutions adopted by the Board of Directors of the Company or a duly authorized
committee thereof approving the transactions contemplated by this Agreement and the other Transaction Documents and the issuance
of the Common Shares, (B) certifying the current version of the Articles of Incorporation, as amended, and bylaws, as amended,
of the Company and (C) certifying as to the signatures and authority of persons signing the Transaction Documents and related documents
on behalf of the Company; and

 

    	7

    	 

    

 

(vii)       the
Compliance Certificate referred to in Section 5.l(f).

 

(b)          Each
Purchaser shall deliver or cause to be delivered to the Company or the Escrow Agent, as applicable, on or prior to the Closing
Date, the following (the “Purchaser Deliverables”):

 

(i)          this
Agreement, duly executed by such Purchaser;

 

(ii)         the
Registration Rights Agreement, duly executed by such Purchaser;

 

(iii)        a
fully completed and duly executed Accredited Investor Questionnaire, reasonably satisfactory to the Company, and the Stock Certificate
Questionnaire in the forms attached hereto as Exhibits B-1 and B-2, respectively; and

 

(iv)        its
Subscription Amount, in United States dollars and in immediately available funds, in the amount indicated below such Purchaser’s
name on the applicable signature page hereto under the heading “Aggregate Purchase Price (Subscription Amount)” by
wire transfer to the Escrow Account in accordance with the Escrow Agent’s written instructions.

 

ARTICLE
3

REPRESENTATIONS AND WARRANTIES

 

3.1         Representations
and Warranties of the Company. The Company hereby represents and warrants as of the date hereof and as of the Closing Date
(except for the representations and warranties that speak as of a specific date, which shall be made as of such date), to each
of the Purchasers that:

 

(a)          Subsidiaries.
The Company has no direct or indirect Subsidiaries except as set forth on Exhibit 21.1 to the Company’s Annual Report on
Form 10-K for the year ended December 31, 2013, filed with the Commission on March 14, 2014, plus Coastal Bankshares Statutory
Trust I and Coastal Bankshares Statutory Trust II, which were each acquired subsequent to such filing date. The Company owns, directly
or indirectly, all of the capital stock or comparable equity interests of each Subsidiary free and clear of any and all Liens,
except as specified in the SEC Reports, and all the issued and outstanding shares of capital stock or comparable equity interests
of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe
for or purchase securities. No equity security of any Subsidiary is or may be required to be issued by reason of any option, warrant,
scrip, preemptive right, right to subscribe to, gross-up right, call or commitment of any character whatsoever relating to, or
security or right convertible into, shares of any capital stock of such Subsidiary, and there are no contracts, commitments, understandings
or arrangements by which any Subsidiary is bound to issue additional shares of its capital stock, or any option, warrant or right
to purchase or acquire any additional shares of its capital stock. Except in respect of the Subsidiaries, the Company does not
beneficially own, directly or indirectly, more than 5% of any class of equity securities or similar interests of any corporation,
bank, business trust, association or similar organization, and is not, directly or indirectly, a partner in any partnership or
party to any joint venture. The Company beneficially owns all of the outstanding capital securities and has sole Control of Ameris
Bank, a Georgia state-chartered bank (the “Bank”).

 

    	8

    	 

    

 

(b)          Organization
and Qualification. The Company and each Subsidiary is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization (as applicable), with the requisite
power and authority to own or lease and use its properties and assets and to carry on its business as currently conducted. Neither
the Company nor any Subsidiary is in violation of any of the provisions of its respective articles or certificate of incorporation,
bylaws or other organizational or charter documents. The Company and each of its Subsidiaries is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
the case may be, would not reasonably be expected to have a Material Adverse Effect. The Company is duly registered as a bank holding
company under the Bank Holding Company Act of 1956, as amended (the “BHCA”). The Bank’s deposit accounts
are insured up to applicable limits by the FDIC, and all premiums and assessments required to be paid in connection therewith have
been paid when due (after giving effect to any applicable extensions). The Bank holds the requisite authority from the GDBF to
do business as a state-chartered banking corporation under the laws of the State of Georgia. The Company and each Subsidiary have
conducted their respective businesses in compliance with all applicable federal, state and foreign laws, orders, judgments, decrees,
rules, regulations and applicable stock exchange requirements, including all laws and regulations restricting activities of bank
holding companies and banking organizations, except for any noncompliance that, individually or in the aggregate, would not reasonably
be expected to have a Material Adverse Effect.

 

(c)          Authorization;
Enforcement; Validity. The Company has the requisite corporate power and authority to enter into and to consummate the
transactions contemplated by each of the Transaction Documents to which it is a party and otherwise to carry out its obligations
hereunder and thereunder, including, without limitation, to issue the Common Shares in accordance with the terms hereof. The Company’s
execution and delivery of each of the Transaction Documents to which it is a party and the consummation by it of the transactions
contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of the Company, and no
further corporate action is required by the Company, its Board of Directors or its shareholders in connection therewith other than
in connection with the Required Approvals. Each of the Transaction Documents to which it is a party has been (or upon delivery
will have been) duly executed by the Company and is, or when delivered in accordance with the terms hereof, will constitute the
legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of
general application, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law. Except for Material
Contracts, there are no shareholders’ agreements, voting agreements or other similar arrangements with respect to the Company’s
capital stock to which the Company is a party or, to the Company’s Knowledge, between or among any of the Company’s
shareholders.

 

    	9

    	 

    

 

(d)          No
Conflicts. The execution, delivery and performance by the Company of the Transaction Documents to which it is a party and
the consummation by the Company of the transactions contemplated hereby or thereby do not and will not (i) conflict with or violate
any provisions of the Company’s or any Subsidiary’s articles or certificate of incorporation or bylaws or otherwise
result in a violation of the organizational documents of the Company or any Subsidiary, (ii) conflict with, or constitute a default
(or an event that with notice or lapse of time or both would result in a default) under, result in the creation of any Lien upon
any of the properties or assets of the Company or any Subsidiary or give to others any rights of termination, amendment, acceleration
or cancellation (with or without notice, lapse of time or both) of, any Material Contract or (iii) subject to the Required Approvals,
conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of
any court or governmental authority to which the Company is subject (including federal and state securities laws and regulations
and the rules and regulations, assuming the correctness of the representations and warranties made by the Purchasers herein, of
any self-regulatory organization to which the Company or its securities are subject, including all applicable Trading Markets),
or by which any property or asset of the Company is bound or affected, except in the case of the immediately preceding clauses
(ii) and (iii), such as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 

(e)          Filings,
Consents and Approvals. Neither the Company nor any of its Subsidiaries is required to obtain any consent, waiver, authorization
or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental
authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents
(including, without limitation, the issuance of the Common Shares) other than (i) the filing with the Commission of one or more
Registration Statements in accordance with the requirements of the Registration Rights Agreement, (ii) filings required by applicable
state securities laws, (iii) the filing of a Notice of Exempt Offering of Securities on Form D with the Commission under Regulation
D of the Securities Act, (iv) the filing of any requisite notices or application(s) to the Principal Trading Market for the issuance
and sale of the Common Shares and the listing of the Common Shares for trading or quotation, as the case may be, thereon in the
time and manner required thereby, (v) the filings required in accordance with Section 4.6 of this Agreement and (vi) those that
have been made or obtained prior to the date of this Agreement (collectively, the “Required Approvals”).

 

(f)          Issuance
of the Common Shares. The issuance of the Common Shares has been duly authorized and, when issued and paid for in accordance
with the terms of the Transaction Documents, will be duly and validly issued, fully paid and non-assessable and free and clear
of all Liens, other than restrictions on transfer provided for in the Transaction Documents or imposed by applicable securities
laws, shall not subject the holders thereof to personal liability and shall not be subject to preemptive or similar rights. Assuming
the accuracy of the representations and warranties of the Purchasers in this Agreement, the Common Shares will be issued in compliance
with all applicable federal and state securities laws.

 

    	10

    	 

    

 

(g)          Capitalization.
The authorized capital stock of the Company consists of (i) 100,000,000 shares of Common Stock and (ii) 5,000,000 shares of preferred
stock. The number of shares and type of all authorized, issued and outstanding capital stock, options and other securities of the
Company (whether or not presently convertible into or exercisable or exchangeable for shares of capital stock of the Company) has
been set forth in the SEC Reports (except that the number of shares of Common Stock outstanding as of October 31, 2014 was 26,777,102,
with the greater number reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014
also including shares of Common Stock held in treasury) and has changed since the date of such SEC Reports only due to stock grants
or other equity awards or stock option exercises that do not, individually or in the aggregate, have a material effect on the number
of issued and outstanding shares of capital stock, options and other securities. All of the outstanding shares of capital stock
of the Company are duly authorized, validly issued, fully paid and non-assessable, have been issued in compliance in all material
respects with all applicable federal and state securities laws, and none of such outstanding shares was issued in violation of
any preemptive rights or similar rights to subscribe for or purchase any capital stock of the Company. Except as specified in the
SEC Reports: (i) no shares of the Company’s outstanding capital stock are subject to preemptive rights or any other similar
rights; (ii) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company
or a Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or a Subsidiary is or may become
bound to issue additional shares of capital stock of the Company or a Subsidiary or options, warrants, scrip, rights to subscribe
to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable
for, any shares of capital stock of the Company or a Subsidiary, other than those issued or granted pursuant to Material Contracts
or equity or incentive plans or arrangements described in the SEC Reports; (iii) there are no material outstanding debt securities,
notes, credit agreements, credit facilities or other agreements, documents or instruments evidencing indebtedness of the Company
or a Subsidiary or by which the Company or a Subsidiary is bound; (iv) except for the Registration Rights Agreement, there are
no agreements or arrangements under which the Company or a Subsidiary is obligated to register the sale of any of its securities
under the Securities Act; (v) there are no outstanding securities or instruments of the Company that contain any redemption or
similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or a Subsidiary
is or may become bound to redeem a security of the Company or a Subsidiary; (vi) neither the Company nor any Subsidiary has any
stock appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement; and (vii) neither
the Company nor any Subsidiary has liabilities or obligations required to be disclosed in the SEC Reports but not so disclosed
in the SEC Reports, which, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. There
are no securities or instruments of the Company containing anti-dilution or similar provisions that will be triggered by the issuance
of the Securities.

 

    	11

    	 

    

 

(h)          SEC
Reports. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by it
under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, since January 1, 2012 (the foregoing materials, including
the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the “SEC
Reports”), on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports
prior to the expiration of any such extension. As of their respective filing dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder,
and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact
necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The
SEC Reports, including the documents incorporated by reference in each of them, each contained the information required to be included
in it. No executive officer of the Company has failed in any respect to make the certifications required of him or her under Section
302 or 906 of the Sarbanes-Oxley Act of 2002.

 

(i)          Financial
Statements. The financial statements of the Company and its Subsidiaries included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect
at the time of filing. Such financial statements have been prepared in accordance with GAAP applied on a consistent basis during
the periods involved, except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited
financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the balance sheet
of the Company and its consolidated Subsidiaries taken as a whole as of and for the dates thereof and the results of operations
and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments,
which would not be material, either individually or in the aggregate.

 

(j)          Tax
Matters. The Company and each of its Subsidiaries have (i) filed all material foreign, U.S. federal, state and local tax
returns, information returns and similar reports that are required to be filed, and all such tax returns are true, correct and
complete in all material respects and (ii) paid all material taxes required to be paid by it and any other material assessment,
fine or penalty levied against it other than taxes (x) currently payable without penalty or interest or (y) being contested in
good faith by appropriate proceedings. The Company has established on its most recent balance sheet included within the SEC Reports
reserves that are adequate for the payment of all taxes not yet due and payable.

 

(k)          Material
Changes. Since the date of the latest audited financial statements included within the SEC Reports, except as disclosed
in subsequent SEC Reports filed prior to the date hereof, (i) there have been no events, occurrences or developments that have
had or would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect, (ii) the Company
has not incurred any material liabilities (contingent or otherwise) other than (A) trade payables, accrued expenses and other liabilities
incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the
Company’s financial statements pursuant to GAAP or required to be disclosed in filings made with the Commission, (iii) the
Company has not altered materially its method of accounting or the manner in which it keeps its accounting books and records, (iv)
the Company has not declared or made any dividend or distribution of cash or other property to its shareholders (other than the
cash dividend declared on December 16, 2014 and paid January 9, 2015 to shareholders of record on December 31, 2014) or purchased,
redeemed or made any agreements to purchase or redeem any shares of its capital stock, (v) the Company has not issued any equity
securities to any officer, director or Affiliate, except as disclosed in Form 4 filings made with the Commission by the grantee
of such securities, and (vi) there has not been any material change or amendment to, or any waiver of any material right by the
Company under, any Material Contract under which the Company or any of its Subsidiaries is bound or subject. Except for the transactions
contemplated by this Agreement, no event, liability or development has occurred or exists with respect to the Company or its Subsidiaries
or their respective business, properties, operations or financial condition that would be required to be disclosed by the Company
under applicable securities laws at the time this representation is made.

 

    	12

    	 

    

 

(l)          Environmental
Matters. (i) Neither the Company nor any of its Subsidiaries is in violation in any material respect of any federal, state,
local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative
interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection
of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface
strata) or wildlife, including, without limitation, laws and regulations relating to the release or threatened release of chemicals,
pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing
materials or mold (collectively, “Hazardous Materials”) or to the manufacture, processing, distribution, use,
treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, “Environmental Laws”),
(ii) the Company and its Subsidiaries have all permits, authorizations and approvals required under any applicable Environmental
Laws and are each in compliance with their requirements in all material respects, (iii) there are no pending or, to the Knowledge
of the Company, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices
of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any of its
Subsidiaries and (iv) there are no events or circumstances that would reasonably be expected to form the basis of an order for
clean-up or remediation, or an action, suit or proceeding by any private party or governmental authority, against or affecting
the Company or any of its Subsidiaries relating to Hazardous Materials or any Environmental Laws.

 

(m)          Litigation.
There is no Action which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction
Documents or the issuance of the Common Shares or (ii) is reasonably likely to have a Material Adverse Effect, individually or
in the aggregate, if there were an unfavorable decision rendered with respect to such Action. There has not been, and to the Company’s
Knowledge there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former
director or executive officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company under the Exchange Act or the Securities Act. There are no outstanding orders,
judgments, injunctions, awards or decrees of any court, arbitrator or governmental or regulatory body against the Company or any
executive officers or directors of the Company in their capacities as such, which individually or in the aggregate, would reasonably
be expected to have a Material Adverse Effect.

 

    	13

    	 

    

 

(n)          Employment
Matters. No labor dispute exists or, to the Company’s Knowledge, is threatened with respect to any of the employees
of the Company or any Subsidiary which would reasonably be expected to have a Material Adverse Effect. To the Company’s Knowledge,
no executive officer is in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of
a third party, and to the Company’s Knowledge, the continued employment of each such executive officer does not subject the
Company or any Subsidiary to any liability with respect to any of the foregoing matters. The Company and each of its Subsidiaries
is in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices,
terms and conditions of employment and wages and hours, except where the failure to be in compliance would not reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect.

 

(o)          Compliance.
Neither the Company nor any of its Subsidiaries (i) is in default under or in violation of (and no event has occurred that has
not been waived that, with notice or lapse of time or both, would result in a default by the Company or any of its Subsidiaries
under), nor has the Company or any of its Subsidiaries received written notice of a claim that it is in default under or that it
is in violation of, any Material Contract (whether or not such default or violation has been waived), (ii) is in violation of any
order of which the Company has been made aware in writing of any court, arbitrator or governmental body having jurisdiction over
the Company or its properties or assets or (iii) is in violation of, or in receipt of written notice that it is in violation of,
any statute, rule or regulation of any governmental authority applicable to the Company or any of its Subsidiaries (including,
without limitation, all regulations and orders of, or agreements with, the FRB, the FDIC, the GDBF, the Equal Credit Opportunity
Act, the Fair Housing Act, the Community Reinvestment Act, the Home Mortgage Disclosure Act and all other applicable fair lending
laws or other laws relating to discrimination, the Bank Secrecy Act, Title V of the Gramm-Leach-Bliley Act and Title III of the
USA PATRIOT Act, and all applicable federal and state privacy laws and regulations) or which would have the effect of revoking
or limiting FDIC deposit insurance, except, in each case under the immediately preceding clauses (i), (ii) and (iii), as would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 

(p)          Regulatory
Permits. The Company and each of its Subsidiaries possess or have applied for all certificates, authorizations, consents
and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective
businesses as currently conducted and as described in the SEC Reports, except where the failure to possess such permits, individually
or in the aggregate, would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, and
neither the Company nor any of its Subsidiaries has received any notice in writing of Proceedings relating to the revocation or
material adverse modification of any such permit.

 

(q)          Title
to Assets. The Company and its Subsidiaries have good and marketable title to all real property and tangible personal property
owned by them which is material to the business of the Company and its Subsidiaries, taken as a whole, in each case free and clear
of all Liens except such as do not materially affect the value of such property or do not interfere with the use made and proposed
to be made of such property by the Company and any of its Subsidiaries. Any real property and facilities held under lease by the
Company and any of its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are
not material and do not materially interfere with the use made and proposed to be made of such property and buildings by the Company
and its Subsidiaries.

 

    	14

    	 

    

 

(r)          Patents
and Trademarks. The Company and its Subsidiaries own, possess, license or can acquire on reasonable terms, or have other
rights to use all foreign and domestic patents, patent applications, trade and service marks, trade and service mark registrations,
trade names, copyrights, inventions, trade secrets, technology, Internet domain names, know-how and other intellectual property
(collectively, the “Intellectual Property”) necessary for the conduct of their respective businesses as now
conducted, except where the failure to own, possess, license or have such rights would not reasonably be expected to have a Material
Adverse Effect. Except as set forth in the SEC Reports or where such violations or infringements would not reasonably be expected
to have, either individually or in the aggregate, a Material Adverse Effect, (i) there are no rights of third parties to any such
Intellectual Property, (ii) there is no infringement by third parties of any such Intellectual Property, (iii) there is no pending
or, to the Company’s Knowledge, threatened action, suit, proceeding or claim by others challenging the Company’s and
its Subsidiaries’ rights in or to any such Intellectual Property, (iv) there is no pending or, to the Company’s Knowledge,
threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property and
(v) there is no pending or, to the Company’s Knowledge, threatened Proceeding by others alleging that the Company or any
Subsidiary infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of others.

 

(s)          Insurance.
The Company and each of the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and
risks and in such amounts as are prudent and customary in the businesses and locations in which and where the Company and the Subsidiaries
are engaged. Neither the Company nor any of its Subsidiaries has received any notice of cancellation of any such insurance, nor,
to the Company’s Knowledge, will it or any Subsidiary be unable to renew their respective existing insurance coverage as
and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
at a cost that would not have a Material Adverse Effect.

 

(t)          Transactions
With Affiliates and Employees. Except as set forth in the SEC Reports and other than the grant of stock options or other
equity awards that are not individually or in the aggregate material in amount, none of the officers or directors of the Company
and, to the Company’s Knowledge, none of the employees of the Company, is presently a party to any transaction with the Company
or to a presently contemplated transaction with the Company (other than for services as employees, officers or directors) that
would be required to be disclosed pursuant to Item 404 of Regulation S-K promulgated under the Securities Act.

 

(u)          Internal
Control Over Financial Reporting. The Company maintains internal control over financial reporting (as such term is defined
in Rule 13a-15(f) under the Exchange Act) designed to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with GAAP and such internal control over financial
reporting was effective as of the date of the most recent SEC Report.

 

    	15

    	 

    

 

(v)         Sarbanes-Oxley;
Disclosure Controls. The Company is in compliance in all material respects with all of the provisions of the Sarbanes-Oxley
Act of 2002 which are applicable to it. The Company maintains disclosure controls and procedures (as such term is defined in Rule
13a-15(e) and 15d-15(e) under the Exchange Act) and such disclosure controls and procedures were effective as of the date of the
most recent SEC Report.

 

(w)          Certain
Fees. No person will have, as a result of the transactions contemplated by this Agreement, any valid right, interest or
claim against or upon the Company or a Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement
or understanding entered into by or on behalf of the Company, other than the Placement Agent with respect to the offer and sale
of the Common Shares (which Placement Agent’s fees are being paid by the Company and have been disclosed to the Purchasers).
The Company shall indemnify, pay and hold each Purchaser harmless against, any liability, loss or expense (including, without limitation,
attorneys’ fees and out-of-pocket expenses) arising in connection with any such right, interest or claim.

 

(x)          Private
Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2 of this
Agreement and the accuracy of the information disclosed in the Accredited Investor Questionnaires, no registration under the Securities
Act is required for the offer and sale of the Common Shares by the Company to the Purchasers under the Transaction Documents. The
issuance and sale of the Common Shares hereunder does not contravene the rules and regulations of the Principal Trading Market.

 

(y)          Registration
Rights. Other than each of the Purchasers under the Registration Rights Agreement, no Person has any right to cause the
Company to effect the registration under the Securities Act of any securities of the Company other than those securities which
are currently registered on an effective registration statement on file with the Commission.

 

(z)          Listing
and Maintenance Requirements. The Company’s Common Stock is registered pursuant to Section 12(b) of the Exchange
Act, and the Company has taken no action designed to terminate the registration of the Common Stock under the Exchange Act nor
has the Company received any notification that the Commission is contemplating terminating such registration. The Company has not,
in the 12 months preceding the date hereof, received written notice from any Trading Market on which the Common Stock is listed
or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market.
The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance in all material
respects with the listing and maintenance requirements for continued trading of the Common Stock on the Principal Trading Market.

 

(aa)         Investment
Company. Neither the Company nor any of its Subsidiaries is required to be registered as, and immediately following the
Closing will not be required to register as, an “investment company” within the meaning of the Investment Company Act
of 1940, as amended, and neither the Company nor any Subsidiary sponsors any person that is such an investment company.

 

    	16

    	 

    

 

(bb)         Unlawful
Payments. Neither the Company nor any of its Subsidiaries has, nor to the Company’s Knowledge, have any directors,
officers, employees, agents or other Persons acting at the direction of or on behalf of the Company or any of its Subsidiaries,
in the course of such Person’s actions for, or on behalf of, the Company or any of its Subsidiaries, (i) directly or indirectly,
used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to foreign or domestic
political activity, (ii) made any direct or indirect unlawful payments to any foreign or domestic governmental officials or employees
or to any foreign or domestic political parties or campaigns from corporate funds, (iii) violated any provision of the Foreign
Corrupt Practices Act of 1977, as amended, or (iv) made any other unlawful bribe, rebate, payoff, influence payment, kickback or
other material unlawful payment to any foreign or domestic government official or employee.

 

(cc)         Application
of Takeover Protections; Rights Agreements. The Company does not have in effect any shareholder rights plan or similar
arrangement relating to accumulations of beneficial ownership of Common Stock or a change in control of the Company. The Company
and its Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition,
business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision
under the Company’s Articles of Incorporation, as amended, or other organizational documents or the laws of Georgia or otherwise
which is or could become applicable to any Purchaser solely as a result of the transactions contemplated by this Agreement, including,
without limitation, the Company’s issuance of the Common Shares and any Purchaser’s ownership of the Common Shares.

 

(dd)         Disclosure.
The Company confirms that neither it nor, to the Company’s Knowledge, any of its officers or directors or any other Person
acting on its or their behalf, including the Placement Agent, has provided any Purchaser or its respective agents or counsel with
any information that it believes constitutes or could reasonably be expected to constitute material, non-public information, except
insofar as (i) the existence, provisions and terms of the Transaction Documents, (ii) the existence of ongoing negotiations regarding
potential bank and branch acquisitions by the Company, (iii) the Company’s preliminary results of operations and related
financial and performance data for the quarter and year ended December 31, 2014 (which, when finally audited by the Company’s
independent auditor, will not, in the aggregate, differ materially from such results of operations as provided to the Purchasers
and included in the Press Release issued pursuant to Section 4.6 hereof), and (iv) the proposed transactions hereunder, may, in
each such case under the immediately preceding clauses (i) through (iv), constitute such information, all of which will be disclosed
by the Company in the Press Release as contemplated by Section 4.6 hereof. The Company understands and confirms that each of the
Purchasers will rely on the representations in this Section 3.1(dd) in effecting transactions in securities of the Company. No
event or circumstance has occurred or information exists with respect to the Company or any of its Subsidiaries or its or their
business, properties, operations or financial conditions, which, under applicable law, rule or regulation, requires public disclosure
or announcement by the Company but which has not been so publicly announced or disclosed, except for the announcement of this Agreement
and related transactions or as may otherwise be disclosed on the Form 8-K filed pursuant to Section 4.6.

 

    	17

    	 

    

 

(ee)         Off-Balance
Sheet Arrangements. There is no transaction, arrangement or other relationship between the Company (or any Subsidiary)
and an unconsolidated or other off-balance sheet entity that is required to be disclosed by the Company in its Exchange Act filings
and is not so disclosed, where such failure to disclose would reasonably be expected to have a Material Adverse Effect.

 

(ff)         Acknowledgment
Regarding Purchasers’ Purchase of Common Stock. The Company acknowledges and agrees that each of the Purchasers is
acting solely in the capacity of an arm’s-length purchaser with respect to the Transaction Documents and the transactions
contemplated hereby and thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary
of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby
and any advice given by any of the Purchasers or any of their respective representatives or agents in connection with the Transaction
Documents and the transactions contemplated thereby is merely incidental to the Purchasers’ purchase of the Common Shares.

 

(gg)         Absence
of Manipulation. The Company has not, and to the Company’s Knowledge no one acting on its behalf has, taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of any of the Common Shares.

 

(hh)         OFAC.
Neither the Company nor any Subsidiary nor, to the Company’s Knowledge, any director, officer, agent, employee, Affiliate
or Person acting on behalf of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office
of Foreign Assets Control of the Treasury (“OFAC”), and the Company will not knowingly use the proceeds of the
sale of the Common Shares towards any sales or operations in any country sanctioned by OFAC or for the purpose of financing the
activities of any Person currently subject to any U.S. sanctions administered by OFAC.

 

(ii)          Money
Laundering Laws. The operations of the Company and its Subsidiaries are in compliance in all material respects with the
money laundering statutes of applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any applicable governmental agency (collectively, the “Money Laundering
Laws”), and, to the Company’s Knowledge, no action, suit or proceeding by or before any court or governmental agency,
authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending
or threatened.

 

(jj)          Reports,
Registrations and Statements. Since January 1, 2012, the Company and each Subsidiary have filed all material reports, registrations
and statements, together with any required amendments thereto, that it was required to file with the FRB, the GDBF and the FDIC
and any other applicable federal or state securities or banking authorities, except where the failure to file any such report,
registration or statement would not reasonably be expected to have a Material Adverse Effect. All such reports and statements filed
with any such regulatory body or authority are collectively referred to herein as the “Company Reports.” As
of their respective dates, the Company Reports complied in all material respects with all applicable rules and regulations promulgated
by the FRB, the GDBF and the FDIC and any other applicable foreign, federal or state securities or banking authorities, as the
case may be.

 

    	18

    	 

    

 

(kk)         Adequate
Capitalization. As of December 31, 2014, the Bank meets or exceeds the standards necessary to be considered “well
capitalized” under the FDIC’s regulatory framework for prompt corrective action.

 

(ll)           Agreements
with Regulatory Agencies. Neither the Company nor any Subsidiary is subject to any cease-and-desist or other similar order
or enforcement action issued by, or is a party to any written agreement, consent agreement or memorandum of understanding with,
or is a party to any commitment letter or similar undertaking to, or is subject to any capital directive by, or since January 1,
2012, has adopted any board resolutions at the request of, any governmental entity that currently restricts in any material respect
the conduct of its business or in any material manner relates to its capital adequacy, its liquidity and funding policies and practices,
its ability to pay dividends, its credit, risk management or compliance policies, its internal controls, its management or its
operations or business.

 

(mm)       No
General Solicitation or General Advertising. Neither the Company nor, to the Company’s Knowledge, any Person acting
on its behalf has engaged or will engage in any form of general solicitation or general advertising (within the meaning of Regulation
D under the Securities Act) in connection with any offer or sale of the Common Shares.

 

(nn)         Risk
Management Instruments. Except as would not reasonably be expected to have a Material Adverse Effect, all material derivative
instruments, including, swaps, caps, floors and option agreements, whether entered into for the Company’s own account, or
for the account of one or more of the Company Subsidiaries, were entered into (i) only in the ordinary course of business, (ii)
in compliance with all applicable laws, rules, regulations and regulatory policies and (iii) with counterparties believed to be
financially responsible at the time. Each such material derivative instrument constitutes the valid and legally binding obligation
of the Company or one of the Subsidiaries, enforceable in accordance with its terms. Neither the Company nor the Subsidiaries,
nor, to the Company’s Knowledge, any other party thereto, is in breach of any such agreement or arrangement in any material
respect.

 

(oo)         ERISA.
The Company and each ERISA Affiliate is in compliance in all material respects with all presently applicable provisions of ERISA;
no “reportable event” described in Section 4043 of ERISA (other than an event for which the 30-day notice requirement
has been waived by applicable regulation) has occurred with respect to any Pension Plan for which the Company would have any liability
that would reasonably be expected to have a Material Adverse Effect; the Company has not incurred and does not expect to incur
liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any Pension Plan or (ii) Sections 412
or 4971 of the Code that would reasonably be expected to have a Material Adverse Effect; and each Pension Plan for which the Company
would have liability that is intended to be qualified under Section 401(a) of the Code is so qualified in all material respects
and nothing has occurred, to the Company’s Knowledge, whether by action or by failure to act, that would cause the loss of
such qualification.

 

    	19

    	 

    

 

(pp)        Shell
Company Status. The Company is not, and has never been, an issuer identified in Rule 144(i)(1) under the Securities Act.

 

(qq)        Registration
Eligibility. The Company is eligible to register the resale of the Common Shares by the Purchasers using Form S-3 promulgated
under the Securities Act.

 

(rr)         No
Additional Agreements. Except with respect to closing mechanics, the Company has no other agreements or understandings
(including, without limitation, side letters) with any Purchaser to purchase Common Shares on terms that are different from those
set forth herein.

 

(ss)         No
Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section
3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this
offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable regulation of the
Commission or any Trading Market on which any of the securities of the Company are listed or quoted.

 

(tt)         Bad
Actor Disqualification.

 

(i)          None
of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating
in the transactions contemplated by this Agreement, any beneficial owner of 20% or more of the Company’s outstanding voting
equity securities (calculated on the basis of voting power), or any promoter (as that term is defined in Rule 405 under the Securities
Act) connected with the Company in any capacity at the Closing Date (each an “Issuer Covered Person”) is subject
to any of the “bad actor” disqualifications described in Rule 506(d)(1)(i) through (viii) under the Securities Act
(a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company
has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company
has complied, to the extent applicable, with its disclosure obligations under Rule 506(e) and has furnished to the Placement Agent
and the Purchasers a copy of any disclosures provided thereunder.

 

(ii)         The
Company is not aware of any person (other than any Issuer Covered Person or Placement Agent Covered Person) that has been or will
be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of the Common Stock. For
the purposes of this subsection, “Placement Agent Covered Person” shall mean Sandler O’Neill & Partners,
L.P., or any of its principals, general partners, managing directors or other officers participating in the transactions contemplated
by this Agreement.

 

(iii)        The
Company, upon becoming aware of the same, will notify the Placement Agent and the Purchasers in writing, prior to the Closing Date,
of (A) any Disqualification Event relating to any Issuer Covered Person and (B) any event that would, with the passage of time,
become a Disqualification Event relating to any Issuer Covered Person.

 

    	20

    	 

    

 

3.2         Representations
and Warranties of the Purchasers. Each Purchaser hereby, for itself and for no other Purchaser, represents and warrants
as of the Closing Date to the Company as follows:

 

(a)          Organization;
Authority. If such Purchaser is an entity, it is duly organized, validly existing and in good standing under the laws of
the jurisdiction of its organization with the requisite corporate or other entity power and authority to enter into and to consummate
the transactions contemplated by the applicable Transaction Documents and otherwise to carry out its obligations hereunder and
thereunder. If such Purchaser is an entity, the execution, delivery and performance by such Purchaser of the transactions contemplated
by this Agreement have been duly authorized by all necessary corporate or, if such Purchaser is not a corporation, such partnership,
limited liability company or other applicable like action, on the part of such Purchaser. If such Purchaser is an entity, each
of this Agreement and the Registration Rights Agreement has been duly executed by such Purchaser, and when delivered by such Purchaser
in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against
it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies
or by other equitable principles of general application.

 

(b)          No
Conflicts. The execution, delivery and performance by such Purchaser of this Agreement and the Registration Rights Agreement
and the consummation by such Purchaser of the transactions contemplated hereby and thereby will not (i) result in a violation of
the organizational documents of such Purchaser (if such Purchaser is an entity), (ii) conflict with, or constitute a default (or
an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or instrument to which such Purchaser is a party or (iii)
result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable
to such Purchaser, except in the case of the immediately preceding clauses (ii) and (iii), for such conflicts, defaults, rights
or violations which would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the
ability of such Purchaser to perform its obligations hereunder.

 

(c)          Investment
Intent. Such Purchaser is acquiring the Common Shares as principal for its own account and not with a view to, or for distributing
or reselling such Common Shares or any part thereof in violation of the Securities Act or any applicable state securities laws,
provided, that by making the representations herein, other than as set forth herein, such Purchaser does not agree to hold any
of the Common Shares for any minimum period of time and reserves the right at all times to sell or otherwise dispose of all or
any part of such Common Shares pursuant to an effective registration statement under the Securities Act or under an exemption from
such registration and in compliance with applicable federal and state securities laws. Such Purchaser is acquiring the Common Shares
hereunder in the ordinary course of its business. Such Purchaser does not presently have any agreement, plan or understanding,
directly or indirectly, with any Person to distribute or effect any distribution of any of the Common Shares (or any securities
which are derivatives thereof) to or through any Person or entity.

 

    	21

    	 

    

 

(d)         Purchaser
Status. At the time such Purchaser was offered the Common Shares, it was, and at the date hereof it is, an “accredited
investor” as defined in Rule 501(a) under the Securities Act. Such Purchaser has provided the information in the Accredited
Investor Questionnaire attached hereto as Exhibit B-1.

 

(e)          Reliance.
The Company and the Placement Agent (on behalf of its clients) will be entitled to rely upon this Agreement and are irrevocably
authorized to produce this Agreement or a copy hereof to (i) any regulatory authority having jurisdiction over the Company and
its Affiliates and (ii) any interested party in any administrative or legal proceeding or official inquiry with respect to the
matters covered hereby, in each case, to the extent required by any court or governmental authority to which the Company is subject,
provided that the Company, to the extent legally permitted, provides such Purchaser with prior written notice of such disclosure.

 

(f)          General
Solicitation. Such Purchaser (i) became aware of the offering of the Common Shares and the Common Shares were offered to
such Purchaser, solely by direct contact between such Purchaser and the Company or the Placement Agent, and not by any other means,
including any form of “general solicitation” or “general advertising” (as such terms are used in Regulation
D promulgated under the Securities Act and interpreted by the Commission), (ii) reached its decision to invest in the Company independently
from any other Purchaser, (iii) has entered into no agreements with shareholders of the Company or other subscribers for the purpose
of controlling the Company or any of its Subsidiaries and (iv) has entered into no agreements with shareholders of the Company
or other subscribers regarding voting or transferring such Purchaser’s interest in the Company.

 

(g)          Direct
Purchase. Such Purchaser is purchasing Common Shares directly from the Company and not from the Placement Agent. The Placement
Agent has not made any representations, declarations or warranties to such Purchaser, express or implied, regarding the Common
Shares, the Company or the Company’s offering of the Common Shares, and the Placement Agent did not offer to sell, or solicit
an offer to buy, any of the Common Shares that such Purchaser proposes to acquire from the Company hereunder.

 

(h)          Experience
of Purchaser. Such Purchaser understands that the purchase of the Common Shares involves substantial risk. Such Purchaser
has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits
and risks of the prospective investment in the Common Shares, whether by reason of such Purchaser’s own business and financial
expertise, the business and financial expertise of certain professional advisors unaffiliated with the Company with whom such Purchaser
has consulted or such Purchaser’s preexisting business relationship with the Company or any of its officers, directors or
controlling persons. Such Purchaser has so evaluated the merits and risks of such investment. Such Purchaser is capable of protecting
its own interests in connection with this investment and has experience as an investor in securities of companies like the Company.
Such Purchaser is able to hold the Common Shares indefinitely if required, is able to bear the economic risk of an investment in
the Common Shares and, at the present time, is able to afford a complete loss of such investment.

 

    	22

    	 

    

 

(i)          Access
to Information. Such Purchaser is sufficiently aware of the Company’s business affairs and financial condition to
reach an informed and knowledgeable decision to acquire the Common Shares. Such Purchaser acknowledges that it has been afforded
(i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company
concerning the terms and conditions of the offering of the Common Shares and the merits and risks of investing in the Common Shares;
(ii) access to information about the Company and the Subsidiaries and their respective financial condition, results of operations,
business, properties, management and prospects sufficient to enable it to evaluate its investment; (iii) the opportunity to obtain
such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment; and (iv) the opportunity to ask questions of management.
Such Purchaser has received all information it deems appropriate for assessing the risk of an investment in the Common Shares.
Neither such inquiries nor any other investigation conducted by or on behalf of such Purchaser or its representatives or counsel
shall modify, amend or affect such Purchaser’s right to rely on the truth, accuracy and completeness of the Company’s
representations and warranties contained in the Transaction Documents. Such Purchaser acknowledges that neither the Company nor
the Placement Agent has made any representation, express or implied, with respect to the accuracy, completeness or adequacy of
any available information, except, with respect to the Company, as expressly set forth in the SEC Reports or to the extent such
information is addressed by the representations and warranties of the Company contained in Section 3.1.

 

(j)          Brokers
and Finders. Other than the Placement Agent with respect to the Company (which fees are to be paid by the Company), to
such Purchaser’s knowledge, no Person will have, as a result of the transactions contemplated by the Transaction Documents,
any valid right, interest or claim against or upon the Company or any Purchaser for any commission, fee or other compensation pursuant
to any agreement, arrangement or understanding entered into by or on behalf of such Purchaser.

 

(k)          Independent
Investment Decision. Such Purchaser has independently evaluated the merits of its decision to purchase Common Shares pursuant
to the Transaction Documents, and such Purchaser confirms that it has not relied on the advice of any other Purchaser’s business
or legal counsel in making such decision. Such Purchaser understands that nothing in this Agreement or any other materials presented
by or on behalf of the Company to such Purchaser in connection with the purchase of the Common Shares constitutes legal, regulatory,
tax or investment advice. Such Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion, has
deemed necessary or appropriate in connection with its purchase of the Common Shares. Such Purchaser understands that the Placement
Agent has acted solely as the agent of the Company in this placement of the Common Stock and such Purchaser has not relied on any
statement, representation or warranty, including any business or legal advice of the Placement Agent or any of its agents, counsel
or Affiliates, in making its investment decision hereunder, and confirms that none of such Persons has made any representations
or warranties to such Purchaser in connection with the transactions contemplated by the Transaction Documents.

 

    	23

    	 

    

 

(l)          ERISA.
If such Purchaser is, or is acting on behalf of, an ERISA Entity, such Purchaser represents and warrants that on the date hereof
(i) the decision to invest assets of the ERISA Entity in the Common Shares was made by fiduciaries independent of the Company or
its Affiliates, which fiduciaries are duly authorized to make such investment decisions and who have not relied on any advice or
recommendations of the Company or its affiliates, (ii) neither the Company nor any of its agents, representatives or Affiliates
have exercised any discretionary authority or control with respect to the ERISA Entity’s investment in the Common Shares,
(iii) the purchase and holding of the Common Shares will not constitute a nonexempt prohibited transaction under ERISA or Section
4975 of the Code or a similar violation under any applicable similar laws and (iv) the terms of the Transaction Documents comply
with the instruments and applicable laws governing such ERISA Entity.

 

(m)         Reliance
on Exemptions. Such Purchaser understands that the Common Shares are being offered and sold to such Purchaser in reliance
on specific exemptions from the registration requirements of U.S. federal and state securities laws and that the Company is relying
in part upon the truth and accuracy of, and such Purchaser’s compliance with, the representations, warranties, agreements,
acknowledgements and understandings of such Purchaser set forth herein in order to determine the availability of such exemptions
and the eligibility of such Purchaser to acquire the Common Shares.

 

(n)          No
Governmental Review. Such Purchaser understands that no U.S. federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Common Shares or the fairness or suitability of the investment
in the Common Shares, nor have such authorities passed upon or endorsed the merits of the offering of the Common Shares. Such Purchaser
understands that the Common Shares are not savings accounts, deposits or other obligations of any bank and are not insured by the
FDIC, including the FDIC’s Deposit Insurance Fund, or any other governmental agency.

 

(o)          Antitrust
and Other Consents, Filings, Etc. No approval, consent, exemption, authorization or other action by, or notice to, or filing
with, any governmental entity or authority or any other person or entity in respect of any law or regulation, including the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended, and the rules and regulations thereunder, is necessary or required, and no lapse
of a waiting period under law applicable to such Purchaser is necessary or required, in each case in connection with the execution,
delivery or performance by such Purchaser of this Agreement or the purchase of the Common Shares contemplated hereby, other than
passivity or anti-association commitments that may be required by the FRB.

 

(p)          Residency.
Such Purchaser’s residence (if an individual) or office in which its investment decision with respect to the Common Shares
was made (if an entity) are located at the address immediately below such Purchaser’s name on its signature page hereto.

 

    	24

    	 

    

 

(q)          Regulatory
Matters. Such Purchaser understands and acknowledges that (i) the Company is a registered bank holding company under the
BHCA and is subject to regulation by the FRB and (ii) acquisitions of interests in bank holding companies are subject to the BHCA
and the Change in Bank Control Act (the “CIBCA”) and may be reviewed by the FRB to determine the circumstances
under which such acquisitions of interests will result in such Purchaser becoming subject to the BHCA or subject to the prior notice
requirements of the CIBCA. Assuming the accuracy of the representations and warranties of the Company contained herein, such Purchaser
represents that neither it nor its Affiliates will, as a result of the transactions contemplated herein, be deemed to (i) own or
control 10% or more of any class of voting securities of the Company or (ii) otherwise control the Company for purposes of the
BHCA or CIBCA. Such Purchaser is not participating and has not participated with any other investor in the offering of the Common
Shares in any joint activity or parallel action towards a common goal between or among such investors of acquiring control of the
Company.

 

(r)          OFAC
and Anti-Money Laundering. Such Purchaser understands, acknowledges, represents and agrees that (i) such Purchaser is not
the target of any sanction, regulation or law promulgated by OFAC, the Financial Crimes Enforcement Network or any other U.S. governmental
entity (“U.S. Sanctions Laws”); (ii) such Purchaser is not owned by, controlled by, under common control with,
or acting on behalf of any person that is the target of U.S. Sanctions Laws; (iii) such Purchaser is not a “foreign shell
bank” and is not acting on behalf of a “foreign shell bank” under applicable Money Laundering Laws; (iv) such
Purchaser’s entry into this Agreement or consummation of the transactions contemplated hereby will not contravene U.S. Sanctions
Laws or applicable Money Laundering Laws; (v) such Purchaser will promptly provide to the Company or any regulatory or law enforcement
authority such information or documentation as may be required to comply with U.S. Sanctions Laws or applicable Money Laundering
Laws; and (vi) the Company may provide to any regulatory or law enforcement authority information or documentation regarding, or
provided by, such Purchaser for the purposes of complying with U.S. Sanctions Laws or applicable Money Laundering Laws.

 

(s)          No
Outside Discussion of Offering. Such Purchaser has not discussed the Offering with any other Person or potential investors
(other than the Company, the Placement Agent and such Purchaser’s authorized representatives), except as expressly permitted
under the terms of this Agreement.

 

(t)          Potential
Company Acquisitions. Such Purchaser is aware of the existence of ongoing negotiations regarding a potential bank holding
company acquisition by the Company and a potential purchase of multiple branches from a single seller by the Company (collectively,
the “Potential Company Acquisitions”). Such Purchaser is also aware of the identity of the other Persons party
to the Potential Company Acquisitions. Such Purchaser and its advisors, if any, have been afforded the opportunity to ask questions
of the Company regarding the Potential Company Acquisitions. Such Purchaser acknowledges that the representations and warranties
set forth in Section 3.1 of this Agreement pertain only to the Company and that the Company has made no representations or warranties
to such Purchaser with respect to the Potential Company Acquisitions or the other Persons party thereto.

 

3.3         No
Additional Representations or Warranties. The Company and each of the Purchasers acknowledge and agree that no party to
this Agreement has made or makes any representations or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in this Article 3 and the Transaction Documents.

 

    	25

    	 

    

 

ARTICLE
4

OTHER AGREEMENTS OF THE PARTIES

 

4.1         Transfer
Restrictions.

 

(a)          Compliance
with Laws. Notwithstanding any other provision of this Article 4, each Purchaser covenants that the Common Shares may be
disposed of only pursuant to an effective registration statement under, and in compliance with the requirements of, the Securities
Act, or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities
Act, and in compliance with any applicable state, federal or foreign securities laws. In connection with any transfer of the Common
Shares other than (i) pursuant to an effective registration statement, (ii) to the Company or (iii) pursuant to Rule 144 (provided
that the transferor provides the Company with reasonable assurances (in the form of a seller representation letter and, if applicable,
a broker representation letter) that such securities may be sold pursuant to such rule), the Company may require the transferor
thereof to provide to the Company and the Transfer Agent, at the transferor’s expense, an opinion of counsel selected by
the transferor and reasonably acceptable to the Company and the Transfer Agent, the form and substance of which opinion shall be
reasonably satisfactory to the Company and the Transfer Agent, to the effect that such transfer does not require registration of
such transferred Common Shares under the Securities Act. As a condition of transfer (other than pursuant to clauses (i), (ii) or
(iii) of the immediately preceding sentence), any such transferee shall agree in writing to be bound by the terms of this Agreement
and shall have the rights of a Purchaser under this Agreement and the Registration Rights Agreement with respect to such transferred
Common Stock.

 

(b)          Legends.
Certificates evidencing the Common Shares shall bear any legend as required by the “blue sky” laws of any state and
a restrictive legend in substantially the following form until such time as they are not required under Section 4.1(c) or applicable
law:

 

THESE SECURITIES HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS.
THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT
FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER
SAID ACT (PROVIDED THAT THE TRANSFEROR PROVIDES THE COMPANY WITH REASONABLE ASSURANCES (IN THE FORM OF A SELLER REPRESENTATION
LETTER AND, IF APPLICABLE, A BROKER REPRESENTATION LETTER) THAT THE SECURITIES MAY BE SOLD PURSUANT TO SUCH RULE). NO REPRESENTATION
IS MADE BY THE ISSUER AS TO THE AVAILABILITY OF THE EXEMPTION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT FOR RESALES OF THESE
SECURITIES.

 

    	26

    	 

    

 

(c)          Removal
of Legends. The restrictive legend set forth in Section 4.1(b) shall be removed and the Company shall issue a certificate
without such restrictive legend or any other restrictive legend to the holder of the Common Shares upon which it is stamped or
issue to such holder by electronic delivery at the applicable balance account at DTC, if (i) such Common Shares are registered
for resale under the Securities Act (provided that, if the Purchaser is selling pursuant to an effective registration statement
filed by the Company, the Purchaser agrees to sell such shares only during such time that such registration statement is effective
and not withdrawn or suspended, and only as permitted by such registration statement), (ii) such Common Shares are sold or transferred
pursuant to Rule 144 (if the transferor is not an Affiliate of the Company) or (iii) such Common Shares are eligible for sale under
Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1)
(or Rule 144(i)(2), if applicable) as to such securities and without volume or manner-of-sale restrictions. Following the earlier
of (i) the Effective Date (as defined in the Registration Rights Agreement) or (ii) Rule 144 becoming available for the resale
of Common Shares, without the requirement for the Company to be in compliance with the current public information required under
144(c)(1) (or Rule 144(i)(2), if applicable) as to the Common Shares and without volume or manner-of-sale restrictions, the Company
shall deliver to the Transfer Agent irrevocable instructions that the Transfer Agent shall issue a certificate representing the
applicable Common Shares without legend upon receipt by the Transfer Agent of the legended certificates for such Common Shares.
Any fees (with respect to the Transfer Agent, Company counsel or otherwise) associated with the removal of such legend shall be
borne by the Company. If a legend is no longer required pursuant to the foregoing, the Company will no later than three (3) Trading
Days following the delivery by a Purchaser to the Company or the Transfer Agent (with notice to the Company) of a legended certificate
or instrument representing such Common Shares (endorsed or with stock powers attached, signatures guaranteed, and otherwise in
form necessary to affect the reissuance or transfer) and a representation letter to the extent required by Section 4.1(a) (such
third Trading Day, the “Legend Removal Date”) deliver or cause to be delivered to such Purchaser a certificate
or instrument (as the case may be) representing such Securities that is free from all restrictive legends. The Company may not
make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth
in this Section 4.1(c). Certificates for Common Stock free from all restrictive legends may be transmitted by the Transfer Agent
to the Purchasers by crediting the account of the Purchaser’s prime broker with DTC as directed by such Purchaser.

 

(d)          Acknowledgement.
Each Purchaser hereunder acknowledges its primary responsibilities under the Securities Act and accordingly will not sell or otherwise
transfer the Common Shares or any interest therein without complying with the requirements of the Securities Act and the rules
and regulations promulgated thereunder. Except as otherwise provided below, while the above-referenced registration statement remains
effective, each Purchaser hereunder may sell the Common Shares in accordance with the plan of distribution contained in the registration
statement and if it does so it will comply therewith and with the related prospectus delivery requirements unless an exemption
therefrom is available or unless the Common Shares are sold pursuant to Rule 144. Each Purchaser, severally and not jointly with
the other Purchasers, agrees that if it is notified by the Company in writing at any time that the registration statement registering
the resale of the Securities is not effective or that the prospectus included in such registration statement no longer complies
with the requirements of Section 10 of the Securities Act, such Purchaser will refrain from selling such Common Shares until such
time as such Purchaser is notified by the Company that such registration statement is effective or such prospectus is compliant
with Section 10 of the Exchange Act, unless such Purchaser is able to, and does, sell such Common Shares pursuant to an available
exemption from the registration requirements of Section 5 of the Securities Act.

 

    	27

    	 

    

 

4.2           Acknowledgment
of Dilution. The Company acknowledges that the issuance of the Common Shares may result in dilution of the outstanding
shares of Common Stock. The Company further acknowledges that its obligations under the Transaction Documents, including, without
limitation, its obligation to issue the Common Shares pursuant to the Transaction Documents, are unconditional and absolute and
not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim
the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of
the other shareholders of the Company.

 

4.3           Furnishing
of Information. In order to enable the Purchasers to sell the Common Shares under Rule 144 of the Securities Act, until
the date that the Purchaser may sell all of its Common Shares without restriction or limitation under Rule 144 (including, without
limitation, the requirement to be in compliance with Rule 144(c)(1)), but not for a period exceeding one year from the Closing,
the Company shall maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and timely file
(or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company
after the date hereof pursuant to the Exchange Act. During such one year period, if the Company is not required to file reports
pursuant to such laws, it will prepare and furnish to the Purchasers and make publicly available the information described in Rule
144(c)(2), if the provision of such information will allow resales of the Common Shares pursuant to Rule 144.

 

4.4           Form
D and Blue Sky. The Company agrees to timely file a Form D with respect to the Common Shares as required under Regulation
D. The Company, on or before the Closing Date, shall take such action as the Company shall reasonably determine is necessary in
order to obtain an exemption, or to qualify the Common Shares, for sale to the Purchasers at the Closing pursuant to this Agreement
under applicable securities or “Blue Sky” laws of the states of the United States (or to obtain an exemption from such
qualification). The Company shall make all filings and reports relating to the offer and sale of the Common Shares required under
applicable securities or “Blue Sky” laws of the states of the United States following the Closing Date.

 

4.5           No
Integration. The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the
Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that will be integrated with the offer or sale of the Common Shares in a manner that would require the
registration under the Securities Act of the sale of the Common Shares to the Purchasers.

 

    	28

    	 

    

 

4.6           Securities
Laws Disclosure; Publicity. On or before 9:00 a.m., eastern time, on the first (1st) Trading Day immediately following
the date of this Agreement, the Company shall issue one or more press releases (collectively, the “Press Release”)
reasonably acceptable to the Purchasers disclosing among other things, (i) the material terms of the transactions contemplated
hereby, (ii) if a definitive agreement has been finalized and executed with respect to either or both of the Potential Company
Acquisitions, the existence of such definitive agreement or agreements, (iii) the Company’s preliminary results of operations
and related financial and performance data for the quarter and year ended December 31, 2014 and (iv) any other material, nonpublic
information that the Company may have provided any Purchaser at any time prior to the filing of the Press Release that continues
to be material, nonpublic information at such time. On or before 5:30 p.m., New York City time, on the fourth Trading Day following
the date of this Agreement, the Company will file a Current Report on Form 8-K with the Commission describing the terms of the
Transaction Documents (and including as exhibits to such Current Report on Form 8-K, the Press Release, the material Transaction
Documents (including, without limitation, this Agreement and the Registration Rights Agreement)), the use of proceeds and such
other disclosures and filings as may be required by the federal securities laws. On or before 5:30 p.m., New York City time, on
the fourth Trading Day immediately following the Closing Date, the Company will file a Current Report on Form 8-K with the Commission
disclosing the funding and closing of the offering and, to the extent necessary, updating the previously filed Current Report on
Form 8-K (and to the extent not previously filed, including as exhibits to such Current Report on Form 8-K the material Transaction
Documents (including, without limitation, this Agreement and the Registration Rights Agreement)) and such other disclosures and
filings as may be required by the federal securities laws. To the extent that the potential transactions contemplated hereby are
publicly disclosed prior to Closing and this Agreement terminates prior to Closing, the Company shall publicly disclose, on or
before 9:00 a.m., New York City time, on the Trading Day immediately following such termination, the termination of the transactions
contemplated hereby. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser or any Affiliate
or investment adviser of any Purchaser, or include the name of any Purchaser or any Affiliate or investment adviser of any Purchaser
in any press release or filing with the Commission (other than the Registration Statement) or Trading Market, without the prior
written consent of such Purchaser, except (i) as required by federal securities law in connection with (A) any registration statement
contemplated by the Registration Rights Agreement and (B) the filing of final Transaction Documents with the Commission, (ii) to
the extent such disclosure is required by law, at the request of the Staff of the Commission or Trading Market regulations, in
which case the Company shall provide the Purchasers with prior written notice of such disclosure permitted under this subclause
(ii). From and after the issuance of the Press Release, no Purchaser shall be in possession of any material, non-public information
received from the Company, any Subsidiary or any of their respective officers, directors or employees or the Placement Agent. Each
Purchaser, severally and not jointly with other Purchasers, covenants that until such time as the transactions contemplated by
this Agreement are publicly disclosed by the Company as described in this Section 4.6, such Purchaser will maintain the confidentiality
of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction).

 

    	29

    	 

    

 

4.7         Non-Public
Information. Except with the express written consent of such Purchaser and unless prior thereto such Purchaser shall have
executed a written agreement regarding the confidentiality and use of such information, the Company shall not, and shall cause
each Subsidiary and each of their respective officers, directors, employees and agents, not to, and each Purchaser shall not directly
solicit the Company, any of its Subsidiaries or any of their respective officers, directors, employees or agents to, provide any
Purchaser with any material, non-public information regarding the Company or any of its Subsidiaries from and after the filing
of the Press Release.

 

4.8         Indemnification.

 

(a)          Indemnification
of Purchasers. In addition to the indemnity provided in the Registration Rights Agreement, the Company will indemnify and hold
each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a
functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person
who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act) and the
directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling person (each,
an “Indemnified Person”) harmless from any and all losses, liabilities, obligations, claims, contingencies,
damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’
fees and costs of investigation (collectively, “Losses”) that any such Indemnified Person may suffer or incur
as a result of (i) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (ii) any action instituted against an Indemnified Person in any capacity, or any of them
or their respective Affiliates, by any shareholder of the Company or other Person, in each case who is not an Affiliate of such
Indemnified Person, with respect to any of the transactions contemplated by this Agreement. The Company will not be liable to any
Indemnified Person under this Agreement to the extent, but only to the extent, that a Loss is attributable to any Indemnified Person’s
breach of any of the representations, warranties, covenants or agreements made by such Indemnified Person in this Agreement or
in the other Transaction Documents or attributable to the gross negligence or willful misconduct on the part of such Indemnified
Person.

 

(b)          Conduct
of Indemnification Proceedings. Promptly after receipt by any Indemnified Person of notice of any demand, claim or circumstances
which would or might give rise to a claim or the commencement of any action, proceeding or investigation in respect of which indemnity
may be sought pursuant to Section 4.8(a), such Indemnified Person shall promptly notify the Company in writing and the Company
shall assume the defense thereof, including the employment of counsel reasonably satisfactory to such Indemnified Person, and shall
assume the payment of all fees and expenses; provided, however, that the failure of any Indemnified Person so to
notify the Company shall not relieve the Company of its obligations hereunder except to the extent that the Company is materially
and adversely prejudiced by such failure to notify. In any such proceeding, any Indemnified Person shall have the right to retain
its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Company
and the Indemnified Person shall have mutually agreed to the retention of such counsel, (ii) the Company shall have failed promptly
to assume the defense of such proceeding and to employ counsel reasonably satisfactory to such Indemnified Person in such proceeding
or (iii) in the reasonable judgment of counsel to such Indemnified Person, representation of both parties by the same counsel would
be inappropriate due to actual or potential differing interests between them; provided, however, that the Indemnifying
Party shall not be liable for the fees and expenses of more than one separate firm of attorneys at any time for all Indemnified
Parties. The Company shall not be liable for any settlement of any proceeding affected without its written consent, which consent
shall not be unreasonably withheld, delayed or conditioned. Without the prior written consent of the Indemnified Person, which
consent shall not be unreasonably withheld, delayed or conditioned, the Company shall not effect any settlement of any pending
or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnity could have been
sought hereunder by such Indemnified Party, unless such settlement includes an unconditional release of such Indemnified Person
from all liability arising out of such proceeding.

 

    	30

    	 

    

 

4.9         Listing
of Common Stock. The Company will use its reasonable best efforts to list the Common Stock for quotation on the NASDAQ
and maintain the listing of the Common Stock on the NASDAQ.

 

4.10       Use
of Proceeds. The Company intends to use the net proceeds from the sale of the Common Shares hereunder to finance the Potential
Company Acquisitions. The Company intends to use any net proceeds not used to finance the Potential Company Acquisitions for general
corporate purposes.

 

4.11       Limitation
on Beneficial Ownership. No Purchaser (and its Affiliates or any other Persons with which it is acting in concert) will
be entitled to purchase a number of Common Shares pursuant to this Agreement that would result in such Purchaser, together with
its affiliates (as such term is defined in the BHCA) becoming, directly or indirectly, the owner for purposes of the BHCA and the
CIBCA of more than 9.9% of the number of shares of Common Stock issued and outstanding.

 

4.12       Conduct
of Business. From the date hereof until the earlier of the Closing Date or the termination of this Agreement in accordance
with its terms, except as contemplated by this Agreement, the Company will, and will cause its Subsidiaries to, operate their business
in the ordinary course consistent with past practice, preserve intact the current business organization of the Company, use commercially
reasonable efforts to retain the services of their employees, consultants and agents and to preserve the current relationships
of the Company and its Subsidiaries with material customers and other Persons with whom the Company and its Subsidiaries have and
intend to maintain significant relations, maintain all of its operating assets in their current condition (normal wear and tear
excepted) and not take or omit to take any action that would constitute a breach of Section 3.1(k).

 

    	31

    	 

    

 

4.13         Avoidance
of Control. Notwithstanding anything to the contrary in this Agreement, neither the Company nor any Subsidiary shall take
any action (including, without limitation, (i) any redemption, repurchase, rescission or recapitalization of Common Stock, or securities
or rights, options or warrants to purchase Common Stock, or securities of any type whatsoever that are, or may become, convertible
into or exchangeable into or exercisable for Common Stock in each case, where each Purchaser is not given the right to participate
in such redemption, repurchase, rescission or recapitalization to the extent of such Purchaser’s pro rata proportion or (ii)
any merger, consolidation or other change of control, that would cause (a) such Purchaser’s or any other Person’s equity
of the Company (together with equity owned by such Purchaser’s or other Person’s affiliates (as such term is used under
the BHCA)) to exceed 9.9% of any class of voting securities of the Company by such Purchaser or any other Person, together with
their respective Affiliates, as applicable) or (b) such Purchaser’s or any other Person’s ownership of any class of
voting securities of the Company (together with the ownership by such Purchaser’s affiliates (as such term is used under
the BHCA) of voting securities of the Company) to exceed 9.9%, or to increase to an amount that would constitute “control”
under the BHCA, the CIBCA or any rules or regulations promulgated thereunder (or any successor provisions) or otherwise cause such
Purchaser to “control” the Company under and for purposes of the BHCA, the CIBCA or any rules or regulations promulgated
thereunder (or any successor provisions), in each case without the prior written consent of such Purchaser or such Person; provided,
however, that the Company shall not be deemed to be in breach of this Section to the extent that it is taking actions authorized
under other Sections of this Agreement. Notwithstanding anything to the contrary in this Agreement, no Purchaser (together with
its affiliates (as such term is used under the BHCA)) shall have the ability to exercise any voting rights of any class of securities
in excess of 9.9% of the total outstanding voting securities of the Company. In the event either the Company or a Purchaser breaches
its obligations under this Section 4.13 or believes that it is reasonably likely to breach such an obligation, it shall promptly
notify the other parties hereto and shall cooperate in good faith with such parties to modify ownership or make other arrangements
or take any other action, in each case, as is necessary to cure or avoid such breach.

 

4.14       Most
Favored Nation. Except with respect to closing mechanics, during the period from the date of this Agreement through the
Closing Date, neither the Company nor its Subsidiaries shall enter into any agreements with any existing or future investors in
the Company or any of its Subsidiaries that have the effect of establishing rights or otherwise benefiting such investor in a manner
more favorable in any material respect to such investor than the rights and benefits established in favor of the Purchasers by
this Agreement, unless, in any such case, the Purchasers have been provided with such rights and benefits.

 

ARTICLE
5

CONDITIONS PRECEDENT TO CLOSING

 

5.1         Conditions
Precedent to the Obligations of the Purchasers to Purchase Common Shares. The obligation of each Purchaser to acquire Common
Shares at the Closing is subject to the fulfillment, on or prior to the Closing Date, of each of the following conditions, any
of which may be waived by such Purchaser (as to itself only):

 

(a)          Representations
and Warranties. The representations and warranties of the Company contained herein shall be true and correct in all material
respects (except for those representations and warranties that are qualified by materiality, which shall be true and correct in
all respects) as of the date hereof and as of the Closing Date, as though made on and as of such date, except for such representations
and warranties that speak as of a specific date.

 

(b)          Performance.
The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions
required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing.

 

    	32

    	 

    

 

(c)          No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any
of the transactions contemplated by the Transaction Documents.

 

(d)          Consents.
Other than the Required Approvals contemplated in Section 3.1(e), the Company shall have obtained in a timely fashion any and all
consents, permits, approvals, registrations and waivers necessary for consummation of the purchase and sale of the Common Shares,
all of which shall be and remain so long as necessary in full force and effect.

 

(e)          Company
Deliverables. The Company shall have delivered the Company Deliverables in accordance with Section 2.2(a).

 

(f)          Compliance
Certificate. The Company shall have delivered to each Purchaser a certificate, dated as of the Closing Date and signed
by its Chief Executive Officer or its Chief Financial Officer, certifying to the fulfillment of the conditions specified in Sections
5.1(a) and (b) in the form attached hereto as Exhibit E.

 

(g)          Termination.
This Agreement shall not have been terminated as to such Purchaser in accordance with Section 6.16 herein.

 

(h)          Minimum
Investment Amounts. The Company shall have received aggregate gross proceeds from the sale of the Common Shares to Purchasers
hereunder of not less than $100,000,000 on or prior to the Closing Date.

 

(i)          Ownership
Limitations. The sale of the Common Shares pursuant to this Agreement will not cause any Purchaser, together with its affiliates
(as such term is used under the BHCA), becoming, directly or indirectly the owner for purposes of the BHCA and the CIBCA of more
than 9.9% of the number of shares of Common Stock issued and outstanding.

 

(j)          Notice
of Disqualification Events. The Company shall not have provided the Purchasers with any notice described in Section 3.1(tt)(iii).

 

(k)          NASDAQ
Approval. The Company shall have received approval of its additional listing application from the NASDAQ covering the Common
Shares.

 

5.2           Conditions
Precedent to the Obligations of the Company to Sell Common Shares. The Company’s obligation to sell and issue the
Common Shares at the Closing is subject to the fulfillment, on or prior to the Closing Date, of the following conditions, any of
which may be waived by the Company:

 

(a)          Representations
and Warranties. The representations and warranties made by each Purchaser in Section 3.2 hereof shall be true and correct
in all material respects (except for those representations and warranties that are qualified by materiality, which shall be true
and correct in all respects) as of the date hereof and as of the Closing Date as though made on and as of such date, except for
representations and warranties that speak as of a specific date.

 

    	33

    	 

    

 

(b)          Performance.
Such Purchaser shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions
required by the Transaction Documents to be performed, satisfied or complied with by such Purchaser at or prior to the Closing
Date.

 

(c)          No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any
of the transactions contemplated by the Transaction Documents.

 

(d)          Consents.
Other than the Required Approvals contemplated in Section 3.1(e), the Company shall have obtained in a timely fashion any and all
consents, permits, approvals, registrations and waivers necessary for consummation of the purchase and sale of the Common Shares,
all of which shall be and remain so long as necessary in full force and effect.

 

(e)          Purchaser
Deliverables. Such Purchaser shall have delivered its Purchaser Deliverables in accordance with Section 2.2(b).

 

(f)          Termination.
This Agreement shall not have been terminated as to such Purchaser in accordance with Section 6.16 herein.

 

(g)          NASDAQ
Approval. The Company shall have received approval of its additional listing application from the NASDAQ covering the Common
Shares.

 

ARTICLE
6

MISCELLANEOUS

 

6.1         Fees
and Expenses. The Company shall pay the reasonable legal fees and expenses of Greenberg Traurig, LLP, counsel to certain
Purchasers, incurred by such Purchasers in connection with the transactions contemplated by the Transaction Documents, up to a
maximum of $20,000, which amount shall be paid directly by the Company to Greenberg Traurig, LLP at the Closing. Except for such
legal fees and expenses and except as otherwise set forth elsewhere in the Transaction Documents, the parties hereto shall be responsible
for the payment of all expenses incurred by them in connection with the preparation and negotiation of the Transaction Documents
and the consummation of the transactions contemplated hereby. The Company shall pay all amounts owed to the Placement Agent relating
to or arising out of the transactions contemplated hereby. The Company shall pay all Transfer Agent fees, stamp taxes and other
taxes and duties levied in connection with the sale and issuance of the Common Shares to the Purchasers.

 

6.2         Entire
Agreement. The Transaction Documents, together with the Exhibits thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and representations,
oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents and exhibits.
At or after the Closing, and without further consideration, the Company and the Purchasers will execute and deliver to the other
such further documents as may be reasonably requested in order to give practical effect to the intention of the parties under the
Transaction Documents.

 

    	34

    	 

    

 

6.3           Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered
via facsimile or e-mail (provided the sender receives a machine-generated confirmation of successful facsimile transmission or
confirmation of receipt of an e-mail transmission) at the facsimile number specified in this Section prior to 5:00 p.m., New York
City time, on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number specified in this Section on a day that is not a Trading Day or later than 5:00 p.m., New
York City time, on any Trading Day, (c) the Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight
courier service with next day delivery specified or (d) upon actual receipt by the party to whom such notice is required to be
given. The address for such notices and communications shall be as follows:

 

If to the Company, to:

Ameris Bancorp

310 First Street, S.E.

Moultrie, Georgia 31768

Attention: Edwin W. Hortman, Jr.

Fax: (229) 890-2235

E-mail: edwin.hortman@amerisbank.com

 

With a copy to:

 

Rogers & Hardin LLP

229 Peachtree Street, N.E.

Suite 2700

Atlanta, Georgia 30303

Attention: Jody L. Spencer

Fax: (404) 230-0972

E-mail: jspencer@rh-law.com

 

If to a Purchaser, only to:

 

The address set forth under such Purchaser’s
name on the signature page hereof;

 

or such other address as may be designated
in writing hereafter, in the same manner, by such party.

 

6.4         Amendments;
Waivers; No Additional Consideration. No amendment or waiver of any provision of this Agreement will be effective with
respect to any party unless made in writing and signed by an officer or a duly authorized representative of such party. No consideration
shall be offered or paid to any Purchaser to amend or consent to a waiver or modification of any provision of any Transaction Document
unless the same consideration is also offered to all Purchasers who then hold Common Shares.

 

    	35

    	 

    

 

6.5         Construction.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party. This Agreement shall be construed as
if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue
of the authorship of any provisions of this Agreement or any of the Transaction Documents.

 

6.6         Successors
and Assigns. The provisions of this Agreement shall inure to the benefit of and be binding upon the parties and their successors
and permitted assigns. This Agreement, or any rights or obligations hereunder, may not be assigned by the Company without the prior
written consent of the Purchasers. Any Purchaser may assign its rights hereunder in whole or in part to any Person to whom such
Purchaser assigns or transfers any Common Shares in compliance with the Transaction Documents and applicable law, provided such
transferee shall agree in writing to be bound, with respect to the transferred Common Shares, by the terms and conditions of this
Agreement that apply to the “Purchasers”.

 

6.7         No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, other than,
solely with respect to the provisions of Section 4.8, the Indemnified Persons.

 

6.8         Governing
Law. This Agreement will be governed by and construed in accordance with the laws of the State of Georgia applicable to
contracts made and to be performed entirely within such State. Each party agrees that all Proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents, or any other matter
related thereto (whether brought against a party hereto or its respective Affiliates, employees or agents) whether in tort or contract
or at law or in equity, may be commenced and maintained non-exclusively in the courts of the State of Georgia, including, without
limitation, the federal district courts located in such State (collectively, the “Georgia Courts”). Each party
hereto hereby irrevocably submits to the non-exclusive jurisdiction of such Georgia Courts for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to
the enforcement of any of the Transaction Documents) and hereby irrevocably waives, and agrees not to assert in any Proceeding,
any claim that it is not personally subject to the jurisdiction of any such Georgia Courts or that such Proceeding has been commenced
in an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal service of process and consents to process
being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner permitted by law. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE
TRANSACTIONS CONTEMPLATED HEREBY.

 

    	36

    	 

    

 

6.9         Survival.
Subject to applicable statutes of limitations, the representations, warranties, agreements and covenants contained herein shall
survive the Closing and the delivery of the Common Shares; provided, however, that (i) the representations and warranties
of the Company set forth in Sections 3.1(c) and 3.1(g) shall survive the Closing and the delivery of the Common Shares until the
expiration of the applicable statutory period of limitations and (ii) the representations and warranties of each Purchaser and
all other representations and warranties of the Company not included in the immediately preceding clause (i) shall survive the
Closing and the delivery of Common Shares for a period of one year.

 

6.10       Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being
understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or e-mail signature
page were an original thereof.

 

6.11       Severability.
If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the
remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt
to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate
such substitute provision in this Agreement.

 

6.12       Replacement
of Common Shares. If any certificate or instrument evidencing any Common Shares is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and
substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
and the Transfer Agent of such loss, theft or destruction and the execution by the holder thereof of a customary lost certificate
affidavit of that fact and an agreement to indemnify and hold harmless the Company and the Transfer Agent for any losses in connection
therewith or, if required by the Transfer Agent, a bond in such form and amount as is required by the Transfer Agent. The applicants
for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the
issuance of such replacement Common Shares. If a replacement certificate or instrument evidencing any Common Shares is requested
due to a mutilation thereof, the Company may require delivery of such mutilated certificate or instrument as a condition precedent
to any issuance of a replacement.

 

6.13       Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of
the Purchasers and the Company may be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described in the
foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation (other than in connection
with any action for a temporary restraining order) the defense that a remedy at law would be adequate.

 

    	37

    	 

    

 

6.14       Payment
Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or
exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from,
disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person
under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action),
then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived
and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

6.15       Independent
Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are
several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
of the obligations of any other Purchaser under any Transaction Document. The decision of each Purchaser to purchase Common Shares
pursuant to the Transaction Documents has been made by such Purchaser independently of any other Purchaser and independently of
any information, materials, statements or opinions as to the business, affairs, operations, assets, properties, liabilities, results
of operations, condition (financial or otherwise) or prospects of the Company or any Subsidiary which may have been made or given
by any other Purchaser or by any agent or employee of any other Purchaser, and no Purchaser and any of its agents or employees
shall have any liability to any other Purchaser (or any other Person) relating to or arising from any such information, materials,
statement or opinions. Nothing contained herein or in any Transaction Document, and no action taken by any Purchaser pursuant thereto,
shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or
create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the
transactions contemplated by the Transaction Documents. Each Purchaser acknowledges that no other Purchaser has acted as agent
for such Purchaser in connection with making its investment hereunder and that no Purchaser will be acting as agent of such Purchaser
in connection with monitoring its investment in the Common Stock or enforcing its rights under the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising
out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined
as an additional party in any proceeding for such purpose. It is expressly understood and agreed that each provision contained
in this Agreement is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and
not between and among the Purchasers.

 

    	38

    	 

    

 

6.16       Termination,
Rescission.

 

(a)          This
Agreement may be terminated and the sale and purchase of the Common Shares abandoned at any time prior to the Closing by either
the Company or any Purchaser (with respect to itself only) upon written notice to the other, if the Closing has not been consummated
on or prior to 5:00 p.m., New York City time, on the Outside Date; provided, however, that the right to terminate
this Agreement under this Section 6.16 shall not be available to any Person whose failure to comply with its obligations under
this Agreement has been the cause of or resulted in the failure of the Closing to occur on or before such time. In the event that
any Purchaser terminates this Agreement with respect to itself, the Company shall give prompt notice of the termination to each
other Purchaser and, as necessary, work in good faith to restructure the transaction to allow each Purchaser that does not exercise
a termination right to purchase the full number of Common Shares set forth below such Purchaser’s name on the signature page
of this Agreement while remaining in compliance with Section 4.11. Nothing in this Section 6.16 shall be deemed to release any
party from any liability for any breach by such party of the terms and provisions of this Agreement or the other Transaction Documents
or to impair the right of any party to compel specific performance by any other party of its obligations under this Agreement or
the other Transaction Documents. In the event of a termination pursuant to this Section 6.16, the Company shall promptly notify
all non-terminating Purchasers. Upon a termination in accordance with this Section 6.16, the Company and the terminating Purchaser(s)
shall not have any further obligation or liability (including arising from such termination) to the other, and no Purchaser will
have any liability to any other Purchaser under the Transaction Documents as a result therefrom.

 

(b)          Notwithstanding
anything to the contrary contained in (and without limiting any similar provisions of) the Transaction Documents, whenever any
Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its
related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from
time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice
to its future actions and rights.

 

(c)          Promptly
following the termination of this Agreement pursuant to this Section 6.16, the Company shall provide written notice to the Escrow
Agent notifying the Escrow Agent that this Agreement has been terminated and advise the Transfer Agent that the share issuance
instructions with respect to such Purchaser shall be null and void. Pursuant to the terms of the Escrow Agreement, the Escrow Agent
shall distribute to each Purchaser such Purchaser’s Subscription Amount.

 

[Signature pages follow.]

 

    	39

    	 

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	 	AMERIS BANCORP
	 	 	 
	 	By:	/s/ Dennis J. Zember Jr.
	 	 	Dennis J. Zember Jr.
	 	 	Executive Vice President and Chief Financial  Officer

 

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK] 

[SIGNATURE PAGES FOR PURCHASERS FOLLOW]

 

[Signature Page to Securities Purchase Agreement]

  

    	 

    	 

    

	 	 
	 	PURCHASER:
	 	 	 
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

	 	Aggregate Purchase Price	 
	 	(Subscription Amount):	$
	 	 	 
	 	Number of Common Shares	 
	 	to be Acquired:	 

 

	 	Tax ID No.:	 

 

	 	Address for Notice:
	 	 
	 	 
	 	 
	 	Attention:	 
	 	Telephone No.:	 
	 	Facsimile No.:	 
	 	E-mail Address:	 
	 	 	 
	 	Wire instructions for return of escrowed funds:
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

Delivery Instructions (if different than above):

	c/o	 	 

	Street:	 	 

	City/State/Zip:	 	 

	Attention:	 	 

	Telephone No.:	 	 

 

[Signature Page to Securities Purchase Agreement]

 

    	 

    	 

    

 

EXHIBITS

 

		A:	Form of Registration Rights Agreement

 

		B-1:	Accredited Investor Questionnaire

 

		B-2:	Stock Certificate Questionnaire

 

		C:	Form of Opinion of Company Counsel

 

		D:	Form of Secretary’s Certificate

 

		E:	Form of Officer’s Certificate

 

		F:	Form of Escrow Agreement

 

    	 

    	 

    

 

EXHIBIT A

 

Form of Registration Rights Agreement

 

    	 

    	 

    

 

EXHIBIT B-1

 

ACCREDITED INVESTOR QUESTIONNAIRE

 

(ALL INFORMATION WILL BE TREATED CONFIDENTIALLY)

 

To: Ameris Bancorp

 

This Investor Questionnaire (“Questionnaire”)
must be completed by each potential investor in connection with the offer and sale of shares of the Common Stock, $1.00 par value
per share (the “Common Shares”), of Ameris Bancorp, a Georgia corporation (the “Corporation”).
The Common Shares are being offered and sold by the Corporation without registration under the Securities Act of 1933, as amended
(the “Securities Act”), and the securities laws of certain states, in reliance on the exemptions contained in
Section 4(a)(2) of the Securities Act and on Regulation D promulgated thereunder and in reliance on similar exemptions under applicable
state laws. The Corporation must determine that a potential investor meets certain suitability requirements before offering or
selling Common Shares to such investor. The purpose of this Questionnaire is to assure the Corporation that each investor will
meet the applicable suitability requirements. The information supplied by you will be used in determining whether you meet such
criteria, and reliance upon the private offering exemptions from registration is based in part on the information herein supplied.

 

This Questionnaire does not constitute an offer to sell or a
solicitation of an offer to buy any security. Your answers will be kept strictly confidential; however, by signing this Questionnaire,
you will be authorizing the Corporation to provide a completed copy of this Questionnaire to such parties as the Corporation deems
appropriate in order to ensure that the offer and sale of the Common Shares will not result in a violation of the Securities Act
or the securities laws of any state and that you otherwise satisfy the suitability standards applicable to purchasers of the Common
Shares. All potential investors must answer all applicable questions and complete, date and sign this Questionnaire. Please print
or type your responses and attach additional sheets of paper if necessary to complete your answers to any item.

 

PART A. BACKGROUND INFORMATION

 

Name of Beneficial Owner of the Common Shares:

 

If a corporation, partnership, limited liability company,
trust or other entity:

 

Telephone Number:

 

Business Address:

 

Type of entity:

 

Were you formed for the purpose of investing
in the securities being offered?

 

Yes __   No __

 

    	 

    	 

    

 

If an individual:

 

Telephone Number:

 

Residence Address:

 

Age:

 

Citizenship:

 

Where registered to vote:

 

Set forth in the space provided below the state(s), if any,
in the United States in which you maintained your residence during the past two years and the dates during which you resided in
each state:

 

Are you a director or executive officer
of the Corporation?

 

Yes __    No __

 

Social Security or Taxpayer Identification No.

 

PART B. ACCREDITED
INVESTOR QUESTIONNAIRE

 

In order for the Company
to offer and sell the Common Shares in conformance with state and federal securities laws, the following information must be obtained
regarding your investor status. Please initial each category applicable to you as a Purchaser of Common Shares.

 

	
        _____(1)
	 	A bank as defined in Section 3(a)(2) of the Securities Act or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity; 
	 	 	 
	_____(2)	 	A broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934; 
	 	 	 
	_____(3)	 	An insurance company as defined in Section 2(13) of the Securities Act; 
	 	 	 
	_____(4)	 	An investment company registered under the Investment Company Act of 1940 or a business development company as defined in Section 2(a)(48) of that act; 
	 	 	 
	_____(5)	 	A Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958; 
	 	 	 
	_____(6)	 	A plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000; 
	 	 	 

 

    	 

    	 

    

 

	_____(7)	 	An employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such act, which is either a bank, savings and loan association, insurance company or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors; 
	 	 	 
	_____(8)	 	A private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940; 
	 	 	 
	_____(9)	 	An organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation, Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring the Common Shares, with total assets in excess of $5,000,000; 
	 	 	 
	_____(10)	 	A trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Common Shares, whose purchase is directed by a sophisticated person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of investing in the Company; 
	 	 	 
	_____(11)	 	A natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of his purchase exceeds $1,000,000 (See Note 11 below); 
	 	 	 
	_____(12)	 	A natural person who had an individual income in excess of $200,000 in each of the two most recent years, or joint income with that person’s spouse in excess of $300,000, in each of those years and has a reasonable expectation of reaching the same income level in the current year; 
	 	 	 
	_____(13)	 	An executive officer or director of the Corporation; 
	 	 	 
	_____(14)	 	An entity in which all of the equity owners qualify under any of the above subparagraphs. If the undersigned belongs to this investor category only, list the equity owners of the undersigned and the investor category which each such equity owner satisfies. 

 

Note 11. For purposes of calculating net
worth under paragraph (11) above:

 

(A) The person’s
primary residence shall not be included as an asset;

 

(B) Indebtedness that
is secured by the person’s primary residence, up to the estimated fair market value of the primary residence at the time
of the sale of securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at
the time of sale of securities exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition
of the primary residence, the amount of such excess shall be included as a liability); and

 

    	 

    	 

    

 

(C) Indebtedness that
is secured by the person’s primary residence in excess of the estimated fair market value of the primary residence at the
time of the sale of securities shall be included as a liability.

 

		A.	FOR EXECUTION BY AN INDIVIDUAL:

 

	 	By:	 
	 	 	 
	Date:     __________    	 	 
	 	Print Name:	 

 

		B.	FOR EXECUTION BY AN ENTITY:

 

	 	Entity Name:	 
	 	 	 
	 	By:	 
	 	 	 
	Date:                                  	 	 
	 	Print Name:	 
	 	Title:	 

 

		C.	ADDITIONAL SIGNATURES (if required by partnership, corporation or trust document):

 

	 	Entity Name:	 
	 	 	 
	 	By:	 
	 	 	 
	Date:                                  	 	 
	 	Print Name:	 
	 	Title:	 
	 	 	 
	 	 	 
	 	Entity Name:	 
	 	 	 
	 	By:	 
	Date:                                  	 	 
	 	 	 
	 	Print Name:	 
	 	 	 
	 	Title:	 

 

    	 

    	 

    

 

EXHIBIT B-2

 

Stock Certificate Questionnaire

 

Pursuant to Section
2.1(b) of the Agreement, please provide the following information:

 

1.          The
exact name that the Common Shares are to be registered in (this is the name that will appear on the stock certificate(s)) (you
may use a nominee if appropriate):                                                        

 

 

 

2.          The
relationship between the Purchaser of the Common Shares and the Registered Holder listed in response to Item 1 above:                                                                                                                                                                            

 

 

 

3.          The
mailing address, telephone and facsimile number of the Registered Holder listed in response to Item 1 above:                                                                                                                                                                                             

 

 

 

4.          The
Tax Identification Number (or, if an individual, the Social Security Number) of the Registered Holder listed in response to Item
1 above:                                                                                                                                             

 

    	 

    	 

    

 

EXHIBIT C

 

Form of Opinion of Company Counsel*

 

1.          The
Company, based solely upon the certificate of existence issued by the Secretary of State of the State of Georgia dated January
[●], 2015, is validly existing under the laws of the State of Georgia.

 

2.          The
Company has the corporate power to execute, deliver and perform its obligations under the Transaction Documents, including to issue
the Common Shares.

 

3.          The
Company is a registered bank holding company under the Bank Holding Company Act of 1956, as amended (the “BHCA”).

 

4.          The
deposit accounts of the Bank are insured by the Federal Deposit Insurance Corporation under the provisions of the Federal Deposit
Insurance Act.

 

5.          The
Company has authorized the execution, delivery and performance of each of the Transaction Documents by all necessary corporate
action, including the issuance of the Common Shares.

 

6.          The
Transaction Documents have been duly executed and delivered by the Company and, assuming due authorization, execution and delivery
by the Purchasers (to the extent they are a party), each of the Transaction Documents is valid, binding and enforceable against
the Company in accordance with its terms.

 

7.          The
execution and delivery of each of the Transaction Documents by the Company, the consummation by the Company of the transactions
provided for in the Transaction Documents and the performance by the Company of its obligations under the Transaction Documents,
including the issuance of the Common Shares, do not: (a) violate any provision of the Company’s Articles of Incorporation,
as amended to date, or Bylaws; (b) violate or constitute a breach of or default under any contract, agreement or instrument filed
as an exhibit to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 or any subsequent Form 10-Q
or Form 8-K filed prior to the Closing Date; or (c) violate any applicable law or any order of any court or governmental authority
that is binding on the Company or any of its assets.

 

8.          No
consent, approval, authorization or other action by, or filing or registration with, any federal governmental authority or any
governmental authority of the State of Georgia or the State of Georgia is required to be obtained or made by the Company for the
execution and delivery by the Company of each of the Transaction Documents, for consummation by the Company of the transactions
provided for therein or for the performance by the Company of its obligations under the Transaction Documents, except for consents,
approvals, authorizations, actions, filings and registrations (a) as may be required by federal securities laws with respect to
the Company’s obligations under the Registration Rights Agreement; (b) related to required blue sky filings; (c) in connection
with the filing of a Form D pursuant to Securities and Exchange Commission Regulation D; (d) required in accordance with Section
4.6 of the Agreement; or (e) in accordance with the listing of the Common Shares on NASDAQ.

 

    	 

    	 

    

 

9.          Assuming
the accuracy of the representations and warranties and compliance with the covenants and agreements of the Purchasers and the Company
contained in the Agreement, it is not necessary, in connection with the offer, sale and delivery of the Common Stock to the Purchasers,
to register the Common Stock under the Securities Act.

 

10.        The
Common Shares to be issued to the Purchasers pursuant to the Agreement have been duly authorized by all necessary corporate action
on the part of the Company and, when issued, delivered and paid for as provided for in the Agreement, will be validly issued, fully
paid and nonassessable and will not be issued in violation of any preemptive right known to us.

 

11.        The
Company is not and, after giving effect to the issuance of the Common Shares, will not be on the date hereof an “investment
company” as defined in the Investment Company Act of 1940, as amended.

 

* The opinion letter of Company Counsel
will be subject to customary limitations and carveouts.

 

    	 

    	 

    

 

EXHIBIT D

 

Form of Secretary’s Certificate

 

The undersigned hereby
certifies that she is the duly elected, qualified and acting Secretary of Ameris Bancorp, a Georgia corporation (the “Company”),
and that as such she is authorized to execute and deliver this certificate in the name and on behalf of the Company and in connection
with the Securities Purchase Agreement, dated as of January 28, 2015, by and among the Company and the investors party thereto
(the “Securities Purchase Agreement”), and further certifies in her official capacity, in the name and on behalf
of the Company, the items set forth below. Capitalized terms used but not otherwise defined herein shall have the meaning set forth
in the Securities Purchase Agreement.

 

1.          Attached
hereto as Exhibit A is a true, correct and complete copy of the resolutions duly adopted by the Board of Directors of the
Company by written consent dated January 22, 2015. Such resolutions have not in any way been amended, modified, revoked or rescinded,
have been in full force and effect since their adoption to and including the date hereof and are now in full force and effect.

 

2.          The
Company’s Articles of Incorporation, as amended, are attached hereto as Exhibit B, and the Company’s Bylaws
are attached hereto as Exhibit C. Such Articles of Incorporation, as amended, and Bylaws, constitute true, correct and complete
copies of the Articles of Incorporation, as amended, and Bylaws as in effect on the date hereof.

 

3.          Each
person listed below has been duly elected or appointed to the position(s) indicated opposite his name and is duly authorized to
sign the Securities Purchase Agreement and each of the Transaction Documents on behalf of the Company, and the signature appearing
opposite such person’s name below is such person’s genuine signature.

 

 

	
        Name
	
 

	
        Position
	
 

	
        Signature

	 	 	 	 	 
	 	 	 	 	 
	Edwin W. Hortman, Jr.	 	Chief Executive Officer	 	 
	 	 	 	 	 
	 	 	 	 	 
	Dennis J. Zember Jr.	 	Chief Financial Officer	 	 

 

    	 

    	 

    

 

IN WITNESS WHEREOF,
the undersigned has hereunto set her hand as of this ___ day of January, 2015.

 

	 	 
	 	
        Secretary 

 

I, Dennis J. Zember Jr., Chief Financial
Officer, hereby certify that Cindi H. Lewis is the duly elected, qualified and acting Corporate Secretary of the Company and that
the signature set forth above is her true signature.

 

	 	 
	 	Chief Financial Officer

 

    	 

    	 

    

 

Exhibit A

 

Resolutions

 

    	 

    	 

    

 

Exhibit B

 

Articles of Incorporation

 

    	 

    	 

    

 

Exhibit C

 

Bylaws

 

    	 

    	 

    

 

EXHIBIT E

 

Form of Officer’s Certificate

 

The undersigned,
the Chief Financial Officer of Ameris Bancorp a Georgia corporation (the “Company”), pursuant to Section 5.1(f)
of the Securities Purchase Agreement, dated as of January 28, 2015 by and among the Company and the investors signatory thereto
(the “Securities Purchase Agreement”), hereby represents, warrants and certifies as follows (capitalized terms
used but not otherwise defined herein shall have the meaning set forth in the Securities Purchase Agreement):

 

1.          The
representations and warranties of the Company contained in the Securities Purchase Agreement are true and correct in all material
respects (except for those representations and warranties that are qualified by materiality, which are true and correct in all
respects) as of the date when made and as of the Closing Date, as though made on and as of such date, except for such representations
and warranties that speak as of a specific date.

 

2.          The
Company has performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by
the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing.

 

IN WITNESS WHEREOF, the undersigned
has executed this certificate this ___ day of January, 2015.

 

	 	By:	 
	 	 	Dennis J. Zember Jr., Chief Financial Officer

 

    	 

    	 

    

 

EXHIBIT F

 

Form of Escrow AgreementExhibit 10.2

 

REGISTRATION RIGHTS AGREEMENT

 

This Registration Rights
Agreement (this “Agreement”) is made and entered into as of January 28, 2015, by and among AMERIS BANCORP,
a corporation organized under the laws of Georgia (the “Company”), and the several purchasers signatory hereto
(each a “Purchaser” and collectively, the “Purchasers”).

 

WHEREAS, this
Agreement is made pursuant to the Securities Purchase Agreement (the “Purchase Agreement”), dated as of the
date hereof between the Company and each Purchaser providing for the sale of shares of common stock of the Company;

 

NOW, THEREFORE,
in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and each of the Purchasers agree as follows:

 

1.            Definitions.
Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given
such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

 

“Advice”
shall have the meaning set forth in Section 6(d).

 

“Affiliate”
means, with respect to any Person, any other Person which directly or indirectly controls, is controlled by or is under common
control with, such Person.

 

“Agreement”
shall have the meaning set forth in the Preamble.

 

“Allowable Grace
Period” shall have the meaning set forth in Section 2(e).

 

“Business Day”
means a day, other than a Saturday or Sunday, on which banks in New York City are open for the general transaction of business.

 

“Closing”
has the meaning set forth in the Purchase Agreement.

 

“Closing Date”
has the meaning set forth in the Purchase Agreement.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Common Stock”
means the common stock of the Company, $1.00 par value per share, and any securities into which such shares of common stock may
hereinafter be reclassified.

 

“Company”
shall have the meaning set forth in the Preamble.

 

“Effective Date”
means the date that the Registration Statement filed pursuant to Section 2(a) is first declared effective by the Commission.

 

    	 

    	 

    

 

“Effectiveness
Deadline” means, with respect to the Initial Registration Statement or the New Registration Statement, the earlier of
(i) the 90th calendar day following the Closing Date (or the 120th calendar day following the Closing Date
in the event that such registration statement is subject to review by the Commission) and (ii) the 5th Trading Day after
the date the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement
will not be “reviewed” or will not be subject to further review; provided, however, that if the Effectiveness
Deadline falls on a Saturday, Sunday or other day that the Commission is closed for business, the Effectiveness Deadline shall
be extended to the next Business Day on which the Commission is open for business.

 

“Effectiveness
Period” shall have the meaning set forth in Section 2(b).

 

“Event”
shall have the meaning set forth in Section 2(c).

 

“Event Date”
shall have the meaning set forth in Section 2(c).

 

“Exchange Act”
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Filing Deadline”
means, with respect to the Initial Registration Statement required to be filed pursuant to Section 2(a), thirty (30) days following
the Closing Date; provided, however, that if the Filing Deadline falls on a Saturday, Sunday or other day that the
Commission is closed for business, the Filing Deadline shall be extended to the next business day on which the Commission is open
for business.

 

“FINRA”
shall have the meaning set forth in Section 3(i).

 

“Grace Period”
shall have the meaning set forth in Section 2(e).

 

“Holder”
or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

 

“Indemnified
Party” shall have the meaning set forth in Section 5(c).

 

“Indemnifying
Party” shall have the meaning set forth in Section 5(c).

 

“Initial Registration
Statement” means the initial Registration Statement filed pursuant to Section 2(a) of this Agreement.

 

“Liquidated
Damages” shall have the meaning set forth in Section 2(c).

 

“Losses”
shall have the meaning set forth in Section 5(a).

 

“New Registration
Statement” shall have the meaning set forth in Section 2(a).

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Principal Market”
means the Trading Market on which the Common Stock is primarily listed on and quoted for trading, which, as of the Closing Date,
shall be the NASDAQ Global Select Market.

 

    	2

    	 

    

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition), whether commenced or threatened.

 

“Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated
under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the
Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.

 

“Purchase Agreement”
shall have the meaning set forth in the Recitals.

 

“Purchaser”
or “Purchasers” shall have the meaning set forth in the Preamble.

 

“Registrable
Securities” means the Common Stock issued pursuant to the Purchase Agreement and any securities issued or issuable upon
any stock split, dividend or other distribution, recapitalization or similar event with respect to such Common Stock, provided
that the Holder has timely completed and delivered to the Company a Selling Shareholder Questionnaire, and provided further that
such Common Stock shall cease to be Registrable Securities upon the earliest to occur of the following: (A) a sale pursuant to
a Registration Statement or Rule 144 under the Securities Act (in which case, only such security sold shall cease to be a Registrable
Security); and (B) becoming eligible for sale without the requirement for the Company to be in compliance with the current public
information required under Rule l44(c)(l) (or Rule l44(i)(2), if applicable) and without volume or manner of sale restrictions
by Holders who are not Affiliates of the Company.

 

“Registration
Statements” means any one or more registration statements of the Company filed under the Securities Act that covers the
resale of any of the Registrable Securities pursuant to the provisions of this Agreement (including, without limitation, the Initial
Registration Statement, the New Registration Statement and any Remainder Registration Statements), amendments and supplements to
such Registration Statements, including post-effective amendments, all exhibits and all material incorporated by reference or deemed
to be incorporated by reference in such Registration Statements.

 

“Remainder Registration
Statement” shall have the meaning set forth in Section 2(a).

 

“Rule 144”
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Rule 415”
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

    	3

    	 

    

 

“Rule 424”
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“SEC Guidance”
means (i) any publicly available written or oral guidance, comments, requirements or requests of the Commission staff and (ii)
the Securities Act.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Selling Shareholder
Questionnaire” means a questionnaire in the form attached as Annex B hereto, or such other form of questionnaire
as may reasonably be adopted by the Company from time to time.

 

“Trading Day”
means (i) a day on which the Common Stock is listed or quoted and traded on its Principal Market or (ii) if the Common Stock is
not listed or quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported
in the “pink sheets” by OTC Markets Group Inc. (or any similar organization or agency succeeding to its functions of
reporting prices); provided, however, that in the event that the Common Stock is not listed or quoted as set forth
in (i) and (ii) hereof, then Trading Day shall mean a Business Day.

 

“Trading Market”
means whichever of the NYSE, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market
or the OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question.

 

    	4

    	 

    

 

2.            Registration.

 

(a)            On or prior to
the Filing Deadline, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all
of the Registrable Securities not already covered by an existing and effective Registration Statement for an offering to be made
on a continuous basis pursuant to Rule 415 or, if Rule 415 is not available for offers and sales of the Registrable Securities,
by such other means of distribution of Registrable Securities as the Company may reasonably determine (the “Initial Registration
Statement”). The Initial Registration Statement shall be on Form S-3 (except if the Company is then ineligible to register
for resale of the Registrable Securities on Form S-3, in which case such registration shall be on such other form available to
the Company to register for resale of the Registrable Securities as a secondary offering) subject to the provisions of Section
2(f) and shall contain (except if otherwise required pursuant to (i) written comments received from the Commission upon a review
of such Registration Statement or (ii) a change in SEC Guidance) the “Plan of Distribution” section substantially in
the form attached hereto as Annex A. Notwithstanding the registration obligations set forth in this Section 2, in the event
the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be
registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly (i) inform each
of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration Statement as
required by the Commission or (ii) withdraw the Initial Registration Statement and file a new registration statement (a “New
Registration Statement”), in either case covering the maximum number of Registrable Securities permitted to be registered
by the Commission, on Form S-3 or such other form available to the Company to register for resale the Registrable Securities as
a secondary offering; provided, however, that prior to filing such amendment or New Registration Statement, the Company
shall be obligated to use its commercially reasonable efforts to advocate with the Commission for the registration of all of the
Registrable Securities in accordance with the SEC Guidance. Notwithstanding any other provision of this Agreement and subject to
the payment of Liquidated Damages in Section 2(c), if any SEC Guidance sets forth a limitation of the number of Registrable Securities
or other shares of Common Stock permitted to be registered on a particular Registration Statement as a secondary offering (and
notwithstanding that the Company used commercial reasonable efforts to advocate with the Commission for the registration of all
or a greater number of Registrable Securities), the number of Registrable Securities or other shares of Common Stock to be registered
on such Registration Statement will be reduced on a pro rata basis based on the total number of unregistered Registrable Securities
held by each Holder. In the event the Company amends the Initial Registration Statement or files a New Registration Statement,
as the case may be, under clauses (i) or (ii) above, the Company will use its commercially reasonable efforts to file with the
Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general,
one or more registration statements on Form S-3 or such other form available to the Company to register for resale those Registrable
Securities that were not registered for resale on the Initial Registration Statement, as amended, or the New Registration Statement
(the “Remainder Registration Statements”). No Holder shall be named as an “underwriter” in any Registration
Statement without such Holder’s prior written consent except if required pursuant to written comments received from the Commission
upon a review of such Registration Statement; provided, however, that prior to naming a Holder as an underwriter
in any Registration Statement, (i) the Company shall use its commercially reasonable efforts to advocate with the Commission against
naming such Holder as an underwriter in accordance with Commission rules and regulations and SEC Guidance and (ii) if, despite
the Company’s commercially reasonable efforts to advocate with the Commission against naming such Holder as an underwriter,
the Commission continues to require that such Holder be named as an underwriter in any Registration Statement, such Holder shall
have the right (but not the obligation), prior to being so named, without any penalty to the Company, to either (A) remove itself
from such Registration Statement or (B) reduce its number of Registrable Securities included in such Registration Statement such
that it shall no longer be required to be named as an underwriter in such Registration Statement.

 

    	5

    	 

    

  

(b)            The Company shall
use its commercially reasonable efforts to cause each Registration Statement to be declared effective by the Commission as soon
as practicable and, with respect to the Initial Registration Statement or the New Registration Statement, as applicable, no later
than the Effectiveness Deadline, and shall use its commercially reasonable efforts to keep each Registration Statement continuously
effective under the Securities Act until the earlier of (i) such time as all of the Registrable Securities covered by such Registration
Statement have been publicly sold by the Holders or (ii) the date that all Registrable Securities covered by such Registration
Statement may be sold by non-affiliates of the Company without volume or manner of sale restrictions under Rule 144, as determined
by counsel to the Company pursuant to a written opinion letter to such effect, addressed and reasonably acceptable to the Company’s
transfer agent and the affected Holders (the “Effectiveness Period”). The Company shall request effectiveness
of a Registration Statement as of 5:00 p.m. New York City time on a Trading Day. The Company shall promptly notify the Holders
via facsimile or electronic mail of a “.pdf” format data file of the effectiveness of a Registration Statement within
one (1) Business Day of the Effective Date. The Company shall, by 9:30 a.m. New York City time on the first Trading Day after the
Effective Date, file a final Prospectus with the Commission, as required by Rule 424(b).

 

(c)            If (i) the Initial
Registration Statement is not filed with the Commission on or prior to the Filing Deadline, (ii) the Initial Registration Statement
or the New Registration Statement, as applicable, is not declared effective by the Commission (or otherwise does not become effective)
for any reason on or prior to the Effectiveness Deadline or (iii) after its Effective Date, (A) such Registration Statement ceases
for any reason (including, without limitation, by reason of a stop order or the Company’s failure to update the Registration
Statement), to remain continuously effective as to all Registrable Securities for which it is required to be effective or (B) the
Holders are not permitted to utilize the Prospectus therein to resell such Registrable Securities, in the case of (A) and (B) (other
than during an Allowable Grace Period (as defined in Section 2(e) of this Agreement)), (iv) a Grace Period (as defined in Section
2(e) of this Agreement) exceeds the length of an Allowable Grace Period or (v) after the date six months following the Closing
Date, and only in the event a Registration Statement is not effective or available to sell all Registrable Securities, the Company
fails to file with the SEC any required reports under Section 13 or 15(d) of the Exchange Act such that it is not in compliance
with Rule 144(c)(1) (or Rule 144(i)(2), if applicable), as a result of which the Holders who are not affiliates are unable to sell
Registrable Securities without restriction under Rule 144 (or any successor thereto) (any such failure or breach in clauses (i)
through (v) above being referred to as an “Event,” and, for purposes of clauses (i), (ii), (iii) or (v), the
date on which such Event occurs, or for purposes of clause (iv) the date on which such Allowable Grace Period is exceeded, being
referred to as an “Event Date”), then in addition to any other rights the Holders may have hereunder or under
applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall
not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash,
as liquidated damages and not as a penalty (“Liquidated Damages”), equal to 0.5% of the aggregate purchase price
paid by such Holder pursuant to the Purchase Agreement for any Registrable Securities held by such Holder on the Event Date. The
parties agree that notwithstanding anything to the contrary herein or in the Purchase Agreement, no Liquidated Damages shall be
payable (i) if as of the relevant Event Date, the Registrable Securities may be sold by non-affiliates without volume or manner
of sale restrictions under Rule 144 and the Company is in compliance with the current public information requirements under Rule
144(c)(1) (or Rule 144(i)(2), if applicable), as determined by counsel to the Company pursuant to a written opinion letter to such
effect, addressed and reasonably acceptable to the Company’s transfer agent, (ii) to a Holder causing an Event that relates
to or is caused by any action or inaction taken by such Holder and (iii) with respect to any period after the expiration of the
Effectiveness Period (it being understood that this sentence shall not relieve the Company of any Liquidated Damages accruing prior
to the Effectiveness Period). If the Company fails to pay any Liquidated Damages pursuant to this Section 2(c) in full within ten
(10) Business Days after the date payable, the Company will pay interest thereon at a rate of 1.0% per month (or such lesser maximum
amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such Liquidated Damages are
due until such amounts, plus all such interest thereon, are paid in full. The Liquidated Damages pursuant to the terms hereof shall
apply on a daily pro-rata basis for any portion of a month prior to the cure of an Event, except in the case of the first Event
Date. With respect to a Purchaser, the Effectiveness Deadline for a Registration Statement shall be extended without default or
Liquidated Damages hereunder in the event that the Company’s failure to obtain the effectiveness of the Registration Statement
on a timely basis results from the failure of such Purchaser to timely provide the Company with information requested by the Company
and necessary to complete the Registration Statement in accordance with the requirements of the Securities Act (in which case the
Effectiveness Deadline would be extended with respect to Registrable Securities held by such Purchaser).

 

    	6

    	 

    

  

(d)            Each Holder agrees
to furnish to the Company a completed Selling Shareholder Questionnaire not more than ten (10) Trading Days following the date
of this Agreement. At least five (5) Trading Days prior to the first anticipated filing date of a Registration Statement for any
registration under this Agreement, the Company will notify each Holder of the information the Company requires from that Holder
other than the information contained in the Selling Shareholder Questionnaire, if any, which shall be completed and delivered to
the Company promptly upon request and, in any event, within two (2) Trading Days prior to the applicable anticipated filing date.
Each Holder further agrees that it shall not be entitled to be named as a selling security holder in the Registration Statement
or use the Prospectus for offers and resales of Registrable Securities at any time, unless such Holder has returned to the Company
a completed and signed Selling Shareholder Questionnaire and a response to any requests for further information as described in
the previous sentence. If a Holder of Registrable Securities returns a Selling Shareholder Questionnaire or a request for further
information, in either case, after its respective deadline, the Company shall use its commercially reasonable efforts at the expense
of the Holder who failed to return the Selling Shareholder Questionnaire or to respond for further information to take such actions
as are required to name such Holder as a selling security holder in the Registration Statement or any pre-effective or post-effective
amendment thereto and to include (to the extent not theretofore included) in the Registration Statement the Registrable Securities
identified in such late Selling Shareholder Questionnaire or request for further information. Each Holder acknowledges and agrees
that the information in the Selling Shareholder Questionnaire or request for further information as described in this Section 2(d)
will be used by the Company in the preparation of the Registration Statement and hereby consents to the inclusion of such information
in the Registration Statement.

 

(e)            Notwithstanding
anything to the contrary herein, at any time after the Registration Statement has been declared effective by the Commission, the
Company may delay the disclosure of material non-public information concerning the Company if the disclosure of such information
at the time is not, in the good faith judgment of the Company, in the best interests of the Company (such delay, a “Grace
Period”); provided, however, that the Company shall promptly (i) notify the Holders in writing of the existence
of material non-public information giving rise to a Grace Period (provided that the Company shall not disclose the content of such
material non-public information to the Holders) or the need to file a post-effective amendment, as applicable, and the date on
which such Grace Period will begin, (ii) use commercially reasonable best efforts to terminate a Grace Period as promptly as practicable
and (iii) notify the Holders in writing of the date on which the Grace Period ends; provided, further, that no single
Grace Period shall exceed forty-five (45) consecutive days, and during any three hundred sixty-five (365) day period, the aggregate
of all Grace Periods shall not exceed an aggregate of ninety (90) days (each Grace Period complying with this provision being an
“Allowable Grace Period”). For purposes of determining the length of a Grace Period, the Grace Period shall
be deemed to begin on and include the date the Holders receive the notice referred to in clause (i) above and shall end on and
include the later of the date the Holders receive the notice referred to in clause (iii) above and the date referred to in such
notice; provided, however, that no Grace Period shall be longer than an Allowable Grace Period. Notwithstanding anything
to the contrary, the Company shall cause the Transfer Agent to deliver unlegended Common Stock to a transferee of a Holder in accordance
with the terms of the Purchase Agreement in connection with any sale of Registrable Securities with respect to which a Holder has
entered into an irrevocable contract for sale prior to the Holder’s receipt of the notice of a Grace Period and for which
the Holder has not yet settled.

 

    	7

    	 

    

 

(f)            In the event that
Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) use commercially
reasonable efforts to register the resale of the Registrable Securities on another appropriate form and (ii) undertake to use commercially
reasonable efforts to register the Registrable Securities on Form S-3 promptly after such form is available; provided, however,
that the Company shall use commercially reasonable efforts to maintain the effectiveness of the Registration Statement then in
effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective
by the Commission.

 

3.            Registration
Procedures. In connection with the Company’s registration obligations hereunder:

 

(a)            The Company shall,
not less than three (3) Trading Days prior to the filing of a Registration Statement and not less than one (1) Trading Day prior
to the filing of any related Prospectus or any amendment or supplement thereto (except for Annual Reports on Form 10-K, Quarterly
Reports on Form 10-Q and Current Reports on Form 8-K and any similar or successor reports), furnish to the Holder copies of such
Registration Statement, Prospectus or amendment or supplement thereto, as proposed to be filed, which documents will be subject
to the reasonable review of such Holder (it being acknowledged and agreed that if a Holder does not object to or comment on the
aforementioned documents within such three (3) Trading Day or one (1) Trading Day period, as the case may be, then the Holder shall
be deemed to have consented to and approved the use of such documents). The Company shall not file any Registration Statement or
amendment or supplement thereto in a form to which a Holder reasonably objects in good faith, accompanied by a specific description
of the objection and the basis therefor, provided that the Company is notified of such objection in writing within the three (3)
Trading Day or one (1) Trading Day period described above, as applicable.

 

    	8

    	 

    

 

(b)            (i) The Company
shall prepare and file with the Commission such amendments (including post-effective amendments) and supplements, to each Registration
Statement and the Prospectus used in connection therewith as may be necessary to keep such Registration Statement continuously
effective as to the applicable Registrable Securities for its Effectiveness Period (except during an Allowable Grace Period); (ii)
the Company shall cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to
the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424 (except during an Allowable
Grace Period); (iii) the Company shall respond as promptly as reasonably practicable to any comments received from the Commission
with respect to each Registration Statement or any amendment thereto and, as promptly as reasonably possible, provide the Holders
true and complete copies of all correspondence from and to the Commission relating to such Registration Statement that pertains
to the Holders as “Selling Shareholders” but not any comments that would result in the disclosure to the Holders of
material and non-public information concerning the Company; and (iv) the Company shall comply with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration Statement until
such time as all of such Registrable Securities shall have been disposed of (subject to the terms of this Agreement) in accordance
with the intended methods of disposition by the Holders thereof as set forth in such Registration Statement as so amended or in
such Prospectus as so supplemented; provided, however, that each Purchaser shall be responsible for the delivery
of the Prospectus to the Persons to whom such Purchaser sells any of the Registrable Securities (including in accordance with Rule
172 under the Securities Act), and each Purchaser agrees to dispose of Registrable Securities in compliance with the plan of distribution
described in the Registration Statement and otherwise in compliance with applicable federal and state securities laws. In the case
of amendments and supplements to a Registration Statement which are required to be filed pursuant to this Agreement (including
pursuant to this Section 3(b)) by reason of the Company filing a report on Form 10-K, Form 10-Q or Form 8-K or any analogous report
under the Exchange Act, the Company shall have incorporated such report by reference into such Registration Statement, if applicable,
or shall file such amendments or supplements with the Commission on the same day on which the Exchange Act report which created
the requirement for the Company to amend or supplement such Registration Statement was filed.

 

(c)            The Company shall
notify the Holders (which notice shall, pursuant to clauses (iii) through (v) hereof, be accompanied by an instruction to suspend
the use of the Prospectus until the requisite changes have been made, but which notice shall not contain any material non-public
information regarding the Company) as promptly as reasonably practicable (and, in the case of (i) (A) below, not less than two
(2) Trading Days prior to such filing, in the case of (iii) and (iv) below, not more than one (1) Trading Day after such issuance
or receipt, and in the case of (v) below, not more than one (1) Trading Day after the occurrence or existence of such development)
and (if requested by any such Person) confirm such notice in writing no later than one (1) Trading Day following the day (i)(A)
when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed;
(B) when the Commission notifies the Company whether there will be a “review” of such Registration Statement and whenever
the Commission comments in writing on any Registration Statement (in which case the Company shall provide to each of the Holders
true and complete copies of all comments that pertain to the Holders as a “Selling Shareholder” or to the “Plan
of Distribution” and all written responses thereto, but not information that the Company believes would constitute material
and non-public information); and (C) with respect to each Registration Statement or any post-effective amendment, when the same
has become effective; (ii) of any request by the Commission or any other federal or state governmental authority for amendments
or supplements to a Registration Statement or Prospectus or for additional information that pertains to the Holders as “Selling
Shareholders” or the “Plan of Distribution”; (iii) of the issuance by the Commission or any other federal or
state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of
the Registrable Securities or the initiation of any Proceedings for that purpose; (iv) of the receipt by the Company of any notification
with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale
in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and (v) of the occurrence of any event
or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or
any statement made in such Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein
by reference untrue in any material respect or that requires any revisions to such Registration Statement, Prospectus or other
documents so that, in the case of such Registration Statement or the Prospectus, as the case may be, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein (in the case of any Prospectus, form of prospectus or supplement thereto, in light of the circumstances under which they
were made), not misleading.

 

    	9

    	 

    

  

(d)            The Company shall
use commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order suspending
the effectiveness of a Registration Statement or (ii) any suspension of the qualification (or exemption from qualification) of
any of the Registrable Securities for sale in any jurisdiction, as soon as practicable.

 

(e)            The Company shall,
if requested by a Holder, furnish to such Holder, without charge, at least one conformed copy of each Registration Statement and
each amendment thereto and all exhibits to the extent requested by such Person (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission; provided, however, that the Company
shall have no obligation to provide any document pursuant to this clause that is available on the Commission’s EDGAR or successor
system.

 

(f)            The Company shall,
prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification)
of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within
the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom)
effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition
in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, however, that
the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject
the Company to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service of
process in any such jurisdiction.

 

(g)            The Company shall
reasonably cooperate with the Holders to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to the Registration Statement, which certificates shall be free, to the extent
permitted by the Purchase Agreement and under law, of all restrictive legends, and to enable such Registrable Securities to be
in such denominations and registered in such names as any such Holders may reasonably request. Certificates for Registrable Securities
free from all restrictive legends may be transmitted by the transfer agent to a Holder by crediting the account of such Holder’s
prime broker with DTC as directed by such Holder.

 

    	10

    	 

    

 

(h)            The Company shall,
following the occurrence of any event contemplated by Section 3(c)(iii)-(v), as promptly as reasonably practicable (taking into
account the Company’s good faith assessment of any adverse consequences to the Company and its shareholders of the premature
disclosure of such event), prepare and file a supplement or amendment, including a post-effective amendment, to the affected Registration
Statements or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference,
and file any other required document so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein (in the case of any Prospectus, form of prospectus or supplement thereto, in light of the circumstances under
which they were made), not misleading.

 

(i)            The Company may
require each selling Holder to furnish to the Company a certified statement as to (i) the number of shares of Common Stock beneficially
owned by such Holder and any Affiliate thereof, (ii) any Financial Industry Regulatory Authority (“FINRA”) affiliations,
(iii) any natural persons who have the power to vote or dispose of the Common Stock and (iv) any other information as may be requested
by the Commission, FINRA, any state securities commission or any other government or regulatory body with jurisdiction over the
Company or its activities. During any periods that the Company is unable to meet its obligations hereunder with respect to the
registration of Registrable Securities because any Holder fails to furnish such information within three (3) Trading Days of the
Company’s request, any Liquidated Damages that are accruing at such time as to such Holder only shall be tolled and any Event
that may otherwise occur solely because of such delay shall be suspended as to such Holder only until such information is delivered
to the Company.

 

(j)            The Company shall
cooperate with any registered broker through which a Holder proposes to resell its Registrable Securities in effecting a filing
with FINRA pursuant to FINRA Rule 5110 as requested by any such Holder and the Company shall pay the filing fee required for the
first such filing (but not additional filings) within two (2) Business Days of the request therefor.

 

(k)            The Company shall
use its commercially reasonable efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration
of the resale of Registrable Securities.

 

(l)            If requested by
a Holder, the Company shall (i) promptly incorporate in a Prospectus supplement or post-effective amendment to the Registration
Statement such information as the Company reasonably agrees (upon advice of counsel) should be included therein and (ii) make all
required filings of such Prospectus supplement or such post-effective amendment as soon as reasonably practicable after the Company
has received notification of the matters to be incorporated in such Prospectus supplement or post-effective amendment.

 

    	11

    	 

    

  

(m)            The Company shall
otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including Rule 172, notify the Holders promptly if the Company no longer satisfies the conditions of
Rule 172 and take such other actions as may be reasonably necessary to facilitate the registration of the Registrable Securities
hereunder.

 

4.            Registration
Expenses. All fees and expenses incident to the Company’s performance of or compliance with its obligations under this
Agreement (excluding any underwriting discounts and selling commissions and all legal fees and expenses of legal counsel for any
Holder) shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement.
The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing
fees (including, without limitation, fees and expenses (A) with respect to filings required to be made with any Trading Market
on which the Common Stock is then listed for trading, (B) with respect to compliance with applicable state securities or Blue Sky
laws (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications
or exemptions of the Registrable Securities and determination of the eligibility of the Registrable Securities for investment under
the laws of such jurisdictions as requested by the Holders) and (C) if not previously paid by the Company in connection with an
Issuer Filing, with respect to any filing that may be required to be made by any broker through which a Holder intends to make
sales of Registrable Securities with FINRA pursuant to FINRA Rule 5110, so long as the broker is receiving no more than a customary
brokerage commission in connection with such sale, (ii) printing expenses (including, without limitation, expenses of printing
certificates for Registrable Securities and of printing prospectuses if the printing of prospectuses is reasonably requested by
the Holders of a majority of the Registrable Securities included in the Registration Statement), (iii) messenger, telephone and
delivery expenses of the Company, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance,
if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection
with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all
of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including,
without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense
of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities
exchange as required hereunder. In no event shall the Company be responsible for any underwriting, broker or similar fees or commissions
of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of any Holder.

 

    	12

    	 

    

 

5.            Indemnification.

 

(a)            Indemnification
by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify, defend and hold harmless each
Holder, the officers, directors, agents, general partners, managing members, managers, Affiliates, employees and investment advisers
of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act) and the officers, directors, general partners, managing members, managers, agents, employees and investment
advisers of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses,
claims, damages, liabilities, costs (including, without limitation, reasonable costs of preparation and investigation and reasonable
and documented attorneys’ fees) and expenses (collectively, “Losses”), as incurred, that arise out of
or are based upon any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus
or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating
to any omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements
therein (in the case of any Prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they
were made) not misleading, except to the extent, but only to the extent, that (A) such untrue statements, alleged untrue statements,
omissions or alleged omissions are based solely upon information regarding such Holder furnished in writing to the Company by such
Holder expressly for use therein (including information provided by any Holder in Annex B, Selling Shareholder Notice and
Questionnaire), or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution
of Registrable Securities and was reviewed and approved by such Holder expressly for use in the Registration Statement, such Prospectus
or such form of Prospectus or in any amendment or supplement thereto (it being understood that each Holder has approved Annex
A hereto for this purpose) or (B) in the case of an occurrence of an event of the type specified in Section 3(c)(iii)-(v),
related to the use by a Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing or
electronic mail that the Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice contemplated
and defined in Section 6(d) below, but only if and to the extent that following the receipt of the Advice the misstatement or omission
giving rise to such Loss would have been corrected. The Company shall notify the Holders promptly of the institution, threat or
assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company
is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of an Indemnified
Party (as defined in Section 5(c)) and shall survive the transfer of the Registrable Securities by the Holders.

 

(b)            Indemnification
by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers,
agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, arising out of or are based upon any untrue or alleged untrue statement
of a material fact contained in any Registration Statement, any Prospectus or any form of prospectus, or in any amendment or supplement
thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact
required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or any form of prospectus
or supplement thereto, in light of the circumstances under which they were made) not misleading (i) to the extent, but only to
the extent, that such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing
to the Company by such Holder expressly for use therein (including information provided by any Holder in Annex B, Selling
Shareholder Notice and Questionnaire) or (ii) to the extent, but only to the extent, that such information relates to such Holder
or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved by such Holder expressly
for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose),
such Prospectus or such form of Prospectus or in any amendment or supplement thereto or (iii) in the case of an occurrence of an
event of the type specified in Section 3(c)(iii)-(v), to the extent, but only to the extent, related to the use by such Holder
of an outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or
defective and prior to the receipt by such Holder of the Advice contemplated in Section 6(d), but only if and to the extent that
following the receipt of the Advice the misstatement or omission giving rise to such Loss would have been corrected. In no event
shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net proceeds received by
such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.

 

    	13

    	 

    

 

(c)            Conduct of
Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought
(the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of one counsel reasonably satisfactory to the Indemnified Party and the payment of all reasonable
and documented fees and expenses incurred in connection with defense thereof; provided, however, that the failure
of any Indemnified Party to give such written notice within a reasonable time of commencement of any such Proceeding shall not
relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that
such failure shall have materially and adversely prejudiced the Indemnifying Party in its ability to defend such Proceeding.

 

An Indemnified Party
shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees
and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (i) the Indemnifying Party has
agreed in writing to pay such fees and expenses; (ii) the Indemnifying Party shall have failed promptly to assume the defense of
such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (iii) the named
parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party,
and such Indemnified Party shall have been advised by counsel that a conflict of interest exists if the same counsel were to represent
such Indemnified Party and the Indemnifying Party; provided, however, that the Indemnifying Party shall not be liable
for the fees and expenses of more than one separate firm of attorneys at any time for all Indemnified Parties. The Indemnifying
Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not
be unreasonably withheld, delayed or unreasonably conditioned. No Indemnifying Party shall, without the prior written consent of
the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless
such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter
of such Proceeding.

 

Subject to the terms
of this Agreement, all documented fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent
incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section
5(c)) shall be paid to the Indemnified Party, as incurred, within twenty (20) Trading Days of written notice thereof to the Indemnifying
Party; provided, however, that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion
of such fees and expenses applicable to such actions for which such Indemnified Party is finally judicially determined to not be
entitled to indemnification hereunder.

 

    	14

    	 

    

 

(d)            Contribution.
If a claim for indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party to hold an Indemnified Party harmless
for any Losses, (even though the Indemnified Party would be entitled to such indemnification pursuant to the Section 5(a) or 5(b)),
then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by
such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying
Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any
other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined
by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material
fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such
Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity
to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall
be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other reasonable
fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified
for such fees or expenses if the indemnification provided for in this Section 5(d) was available to such party in accordance with
its terms.

 

The parties hereto agree
that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or
by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding
paragraph. Notwithstanding the provisions of this Section 5(d), no Holder shall be required to contribute, in the aggregate, any
amount in excess of the amount by which the net proceeds actually received by such Holder from the sale of the Registrable Securities
subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of such
untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation.

 

The indemnity and
contribution agreements contained in this Section 5 are in addition to any liability that the Indemnifying Parties may have to
the Indemnified Parties and are not in diminution or limitation of the indemnification provisions under the Purchase Agreement.

 

6.            Miscellaneous.

 

(a)            Remedies.
In the event of a breach by the Company or by a Holder of any of their obligations under this Agreement, each Holder or the Company,
as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery
of damages, will be entitled to specific performance of its rights under this Agreement. The Company and each Holder agree that
monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions
of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach,
it shall waive the defense that a remedy at law would be adequate.

 

    	15

    	 

    

 

(b)            No Piggyback
on Registrations; Prohibition on Filing Other Registration Statements. Neither the Company nor any of its security holders
may include securities of the Company in a Registration Statement hereunder and the Company shall not prior to the Effective Date
enter into any agreement providing any such right to any of its security holders. The Company shall not, from the date hereof until
the date that is thirty (30) days after the Effective Date of the Initial Registration Statement, prepare and file with the Commission
a registration statement relating to an offering for its own account under the Securities Act of any of its equity securities,
other than (i) a registration statement on Form S-8, (ii) in connection with an acquisition or similar transaction, on Form S-4
or (iii) a registration statement to register for resale securities issued by the Company pursuant to acquisitions or similar transaction
or strategic transactions approved by a majority of the disinterested directors of the Company, provided that any such issuance
shall only be to a Person which is, itself or through its subsidiaries, an operating company in a business synergistic with the
business of the Company and in which the Company receives benefits in addition to the investment of funds, but shall not include
a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary
business is investing in securities. For the avoidance of doubt, the Company shall not be prohibited from preparing and filing
with the Commission a registration statement relating to an offering of Common Stock by existing shareholders of the Company under
the Securities Act pursuant to the terms of registration rights held by such shareholder or from filing amendments to registration
statements filed prior to the date of this Agreement.

 

(c)            Compliance.
Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable
to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant to the Registration
Statement and shall sell the Registrable Securities only in accordance with a method of distribution described in the Registration
Statement.

 

(d)            Discontinued
Disposition. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company
of the occurrence of any event of the kind described in Section 3(c)(iii)-(v), such Holder will forthwith discontinue disposition
of such Registrable Securities under a Registration Statement until it is advised in writing (the “Advice”)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company
may provide appropriate stop orders to enforce the provisions of this paragraph.

 

(e)            No Inconsistent
Agreements. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any
of its Subsidiaries, on or after the date hereof, enter into any agreement with respect to its securities, that would have the
effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof.

 

    	16

    	 

    

  

(f)            Amendments
and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented
or waived unless the same shall be in writing and signed by the Company and Holders holding at least two-thirds of the then outstanding
Registrable Securities, provided that any party may give a waiver as to itself. Notwithstanding the foregoing, a waiver or consent
to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of Holders and that does not
directly or indirectly affect the rights of other Holders may be given by Holders of all of the Registrable Securities to which
such waiver or consent relates; provided, however, that the provisions of this sentence may not be amended, modified
or supplemented except in accordance with the provisions of the immediately preceding sentence. Notwithstanding the foregoing,
if any such amendment, modification or waiver would adversely affect in any material respect any Holder or group of Holders who
have comparable rights under this Agreement disproportionately to the other Holders having such comparable rights, such amendment,
modification or waiver shall also require the written consent of the Holder(s) so adversely affected.

 

(g)            Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as
set forth in the Purchase Agreement; provided, however, that the Company may deliver to each Holder the documents
required to be delivered to such Holder under Section 3(a) of this Agreement by e-mail to the e-mail addresses provided by such
Holder to the Company solely for such specific purpose.

 

(h)            Successors
and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each
of the parties and shall inure to the benefit of each Holder. Nothing in this Agreement, express or implied, is intended to confer
upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities
under or by reason of this Agreement, except as expressly provided in this Agreement. The Company may not assign its rights (except
by merger or in connection with another entity acquiring all or substantially all of the Company’s assets) or obligations
hereunder without the prior written consent of all the Holders of the then outstanding Registrable Securities. Each Holder may
assign its respective rights hereunder in the manner and to the Persons as permitted under the Purchase Agreement.

 

(i)            Execution and
Counterparts. This Agreement may be executed in two or more counterparts, each of which when so executed shall be deemed to
be an original and, all of which taken together shall constitute one and the same Agreement and shall become effective when counterparts
have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart.
In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data
file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such facsimile or “.pdf” signature were the original thereof.

 

(j)            Governing Law.
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in accordance
with the provisions of the Purchase Agreement.

 

    	17

    	 

    

 

(k)            Cumulative
Remedies. Except as provided in Section 2(c) with respect to Liquidated Damages, the remedies provided herein are cumulative
and not exclusive of any other remedies provided by law.

 

(l)            Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their good faith reasonable
efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such
term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.

 

(m)            Headings.
The headings in this Agreement are for convenience only and shall not limit or otherwise affect the meaning hereof.

 

(n)            Independent
Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under this Agreement are several and
not joint with the obligations of any other Purchaser hereunder, and no Purchaser shall be responsible in any way for the performance
of the obligations of any other Purchaser hereunder. The decision of each Purchaser to purchase the Common Stock pursuant to the
Transaction Documents has been made independently of any other Purchaser. Nothing contained herein or in any other agreement or
document delivered at any closing, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute
the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the
Purchasers are in any way acting in concert with respect to such obligations or the transactions contemplated by this Agreement.
Each Purchaser acknowledges that no other Purchaser has acted as agent for such Purchaser in connection with making its investment
hereunder and that no Purchaser will be acting as agent of such Purchaser in connection with monitoring its investment in the Common
Stock or enforcing its rights under the Transaction Documents. Each Purchaser shall be entitled to protect and enforce its rights,
including, without limitation, the rights arising out of this Agreement, and it shall not be necessary for any other Purchaser
to be joined as an additional party in any Proceeding for such purpose. The Company acknowledges that each of the Purchasers has
been provided with the same Registration Rights Agreement for the purpose of closing a transaction with multiple Purchasers and
not because it was required or requested to do so by any Purchaser. It is expressly understood and agreed that each provision contained
in this Agreement is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and
not between and among the Purchasers.

 

[Signature pages follow.]

 

    	18

    	 

    

  

IN WITNESS WHEREOF,
the parties have executed this Registration Rights Agreement as of the date first written above.

 

	 	AMERIS BANCORP
	 	 	 
	 	By:	/s/ Dennis J. Zember Jr.
	 	 	Dennis J. Zember Jr.
	 	 	Executive Vice President and Chief Financial Officer 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK] 

[SIGNATURE PAGES OF HOLDERS TO FOLLOW]

 

[Signature Page to Registration Rights Agreement]

 

    	 

    	 

    

 

IN WITNESS WHEREOF,
the parties have executed this Registration Rights Agreement as of the date first written above.

 

	 	NAME OF INVESTING ENTITY:
	 	 	 
	 	 	 
	 	AUTHORIZED SIGNATORY
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 
	 	 	 
	 	ADDRESS FOR NOTICE
	 	 	 
	 	c/o:	 
	 	Street:	 
	 	 	 
	 	City/State/Zip:	 
	 	 	 
	 	Attention:	 
	 	 	 
	 	Telephone:	 
	 	 	 
	 	Fax:	 
	 	 	 
	 	Email:	 

 

[Signature Page to Registration Rights Agreement]

  

    	 

    	 

    

 

Annex A

 

PLAN OF DISTRIBUTION

 

We are registering
the Common Stock issued to the selling shareholders to permit the resale of the Common Stock by the holders of the Common Stock
from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the selling shareholders
of the Common Stock. We will bear all fees and expenses incident to our obligation to register the Common Stock.

 

The selling shareholders
may sell all or a portion of the Common Stock beneficially owned by them and offered hereby from time to time directly or through
one or more underwriters, broker-dealers or agents. If the Common Stock is sold through underwriters or broker-dealers, the selling
shareholders will be responsible for underwriting discounts or commissions or agent’s commissions. The Common Stock may be
sold on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale,
in the over-the-counter market or in transactions otherwise than on these exchanges or systems or in the over the-counter market
and in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined
at the time of sale or at negotiated prices. These sales may be effected in transactions, which may involve crosses or block transactions.
The selling shareholders may use any one or more of the following methods when selling the Common Stock:

 

		·	ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

 

		·	block trades in which the broker-dealer will attempt to sell the shares as agent but may position
and resell a portion of the block as principal to facilitate the transaction;

 

		·	purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

 

		·	an exchange distribution in accordance with the rules of the applicable exchange;

 

		·	privately negotiated transactions;

 

		·	settlement of short sales entered into after the effective date of the registration statement of
which this prospectus is a part;

 

		·	broker-dealers may agree with the selling shareholders to sell a specified number of such securities
at a stipulated price per share;

 

		·	through the writing or settlement of options or other hedging transactions, whether such options
are listed on an options exchange or otherwise;

 

		·	a combination of any such methods of sale; and

 

		·	any other method permitted pursuant to applicable law.

    	A-1

    	 

    

 

The selling shareholders
also may resell all or a portion of the Common Stock in open market transactions in reliance upon Rule 144 under the Securities
Act, as permitted by that rule, or Section 4(a)(1) under the Securities Act, if available, rather than under this prospectus, provided
that they meet the criteria and conform to the requirements of those provisions.

 

Broker-dealers engaged
by the selling shareholders may arrange for other broker-dealers to participate in sales. If the selling shareholders effect such
transactions by selling Common Stock to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or
agents may receive commissions in the form of discounts, concessions or commissions from the selling shareholders or commissions
from purchasers of the Common Stock for whom they may act as agent or to whom they may sell as principal. Such commissions will
be in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction
will not be in excess of a customary brokerage commission in compliance with NASD Rule 2440, and in the case of a principal transaction
a markup or markdown in compliance with NASD Rule IM 2440.

 

In connection with
sales of the Common Stock or otherwise, the selling shareholders may enter into hedging transactions with broker-dealers or other
financial institutions, which may in turn engage in short sales of the Common Stock in the course of hedging in positions they
assume. The selling shareholders may also sell Common Stock short and if such short sale shall take place after the date that this
Registration Statement is declared effective by the Commission, the selling shareholders may deliver the Common Stock covered by
this prospectus to close out short positions and to return borrowed shares in connection with such short sales. The selling shareholders
may also loan or pledge Common Stock to broker-dealers that in turn may sell such shares, to the extent permitted by applicable
law. The selling shareholders may also enter into option or other transactions with broker-dealers or other financial institutions
or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution
of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this
prospectus (as supplemented or amended to reflect such transaction). Notwithstanding the foregoing, the selling shareholders have
been advised that they may not use shares registered on this registration statement to cover short sales of our Common Stock made
prior to the date the registration statement, of which this prospectus forms a part, has been declared effective by the SEC.

 

The selling shareholders
may, from time to time, pledge or grant a security interest in some or all of the Common Stock owned by them and, if they default
in the performance of their secured obligations, the pledgees or secured parties may offer and sell the Common Stock from time
to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the
Securities Act of 1933, as amended, amending, if necessary, the list of selling shareholders to include the pledgee, transferee
or other successors in interest as selling shareholders under this prospectus. The selling shareholders also may transfer and donate
the Securities in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the
selling beneficial owners for purposes of this prospectus.

    	A-2

    	 

    

 

To the extent required
by the Securities Act and the rules and regulations thereunder, the selling shareholders and any broker-dealer or agents participating
in the distribution of the Common Stock may be deemed to be “underwriters” within the meaning of Section 2(11) of the
Securities Act in connection with such sales. In such event, any commissions paid, or any discounts or concessions allowed to,
any such broker-dealer or agent and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions
or discounts under the Securities Act. Selling Shareholders who are “underwriters” within the meaning of Section 2(11)
of the Securities Act will be subject to the applicable prospectus delivery requirements of the Securities Act and may be subject
to certain statutory liabilities of, including but not limited to, Sections 11, 12 and 17 of the Securities Act and Rule
10b-5 under the Securities Exchange Act of 1934, as amended, or the Exchange Act.

 

Each selling shareholder
has informed the Company that it is not a registered broker-dealer and does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the Common Stock. Upon the Company being notified in writing by a selling
shareholder that any material arrangement has been entered into with a broker-dealer for the sale of Common Stock through a block
trade, special offering, exchange distribution or secondary distribution or a purchase by a broker or dealer, a supplement to this
prospectus will be filed, if required, pursuant to Rule 424(b) under the Securities Act, disclosing (i) the name of each such selling
shareholder and of the participating broker-dealer(s), (ii) the number of shares involved, (iii) the price at which such the shares
of Common Stock were sold, (iv) the commissions paid or discounts or concessions allowed to such broker-dealer(s), where applicable,
(v) that such broker-dealer(s) did not conduct any investigation to verify the information set out or incorporated by reference
in this prospectus, and (vi) other facts material to the transaction. In no event shall any broker-dealer receive fees, commissions
and markups, which, in the aggregate, would exceed eight percent (8%).

 

Under the securities
laws of some states, the Common Stock may be sold in such states only through registered or licensed brokers or dealers. In addition,
in some states the Common Stock may not be sold unless such shares have been registered or qualified for sale in such state or
an exemption from registration or qualification is available and is complied with.

 

There can be no assurance
that any selling shareholder will sell any or all of the Common Stock registered pursuant to the shelf registration statement,
of which this prospectus forms a part.

 

Each selling shareholder
and any other person participating in such distribution will be subject to applicable provisions of the Securities Exchange Act
of 1934, as amended, and the rules and regulations thereunder, including, without limitation, to the extent applicable, Regulation
M of the Exchange Act, which may limit the timing of purchases and sales of any of the Common Stock by the selling shareholder
and any other participating person. To the extent applicable, Regulation M may also restrict the ability of any person engaged
in the distribution of the Common Stock to engage in market-making activities with respect to the Common Stock. All of the foregoing
may affect the marketability of the Common Stock and the ability of any person or entity to engage in market-making activities
with respect to the Common Stock.

    	A-3

    	 

    

  

We will pay all expenses
of the registration of the Common Stock pursuant to the registration rights agreement, including, without limitation, Securities
and Exchange Commission filing fees and expenses of compliance with state securities or “blue sky” laws; provided,
however, that each selling shareholder will pay all underwriting discounts and selling commissions, if any and any related
legal expenses incurred by it. We will indemnify the selling shareholders against certain liabilities, including some liabilities
under the Securities Act, in accordance with the registration rights agreement, or the selling shareholders will be entitled to
contribution. We may be indemnified by the selling shareholders against civil liabilities, including liabilities under the Securities
Act, that may arise from any written information furnished to us by the selling shareholders specifically for use in this prospectus,
in accordance with the related registration rights agreements, or we may be entitled to contribution.

 

    	A-4

    	 

    

 

Annex B 

 

AMERIS BANCORP 

SELLING SHAREHOLDER NOTICE AND QUESTIONNAIRE

 

The undersigned holder
of securities of Ameris Bancorp, a Georgia corporation (the “Company”), issued pursuant to a certain Securities
Purchase Agreement by and among the Company and the Purchasers named therein, dated as of January 28, 2015, understands that the
Company intends to file with the Securities and Exchange Commission a registration statement on Form S-3 (the “Resale
Registration Statement”) for the registration and the resale under Rule 415 of the Securities Act of 1933, as amended
(the “Securities Act”), of the Registrable Securities in accordance with the terms of a certain Registration
Rights Agreement by and among the Company and the Purchasers named therein, dated as of January 28, 2015 (the “Agreement”).
All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Agreement.

 

In order to sell or
otherwise dispose of any Registrable Securities pursuant to the Resale Registration Statement, a holder of Registrable Securities
generally will be required to be named as a selling shareholder in the related prospectus or a supplement thereto (as so supplemented,
the “Prospectus”), deliver the Prospectus to purchasers of Registrable Securities (including pursuant to Rule
172 under the Securities Act) and be bound by the provisions of the Agreement (including certain indemnification provisions, as
described below). Holders must complete and deliver this Notice and Questionnaire in order to be named as selling shareholders
in the Prospectus. Holders of Registrable Securities who do not complete, execute and return this Notice and Questionnaire within
ten (10) Trading Days following the date of the Agreement (1) will not be named as selling shareholders in the Resale Registration
Statement or the Prospectus and (2) may not use the Prospectus for resales of Registrable Securities.

 

Certain legal consequences
arise from being named as a selling shareholder in the Resale Registration Statement and the Prospectus. Holders of Registrable
Securities are advised to consult their own securities law counsel regarding the consequences of being named or not named as a
selling shareholder in the Resale Registration Statement and the Prospectus.

 

NOTICE

 

The undersigned holder
(the “Selling Shareholder”) of Registrable Securities hereby gives notice to the Company of its intention to
sell or otherwise dispose of Registrable Securities owned by it and listed below in Item (3), unless otherwise specified in Item
(3), pursuant to the Resale Registration Statement. The undersigned, by signing and returning this Notice and Questionnaire, understands
and agrees that it will be bound by the terms and conditions of this Notice and Questionnaire and the Agreement.

 

The undersigned hereby
provides the following information to the Company and represents and warrants that such information is accurate and complete:

 

    	B-1

    	 

    

 

QUESTIONNAIRE

 

		1.	Name.

 

	 	(a)	Full Legal Name of Selling Shareholder:  
	 	 	 
	 	(b)	Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities Listed in Item 3 below are held:  
	 	 	 
	 	(c)	Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by the questionnaire):  

 

		2.	Address for Notices to Selling Shareholder:

 

Telephone:

 

Fax:

 

Contact Person:

 

E-mail address of Contact Person:

 

		3.	Beneficial Ownership of Registrable Securities Issuable Pursuant to the Purchase Agreement:

 

	 	(a)	Type and Number of Registrable Securities beneficially owned and issued pursuant to the Agreement:  
	 	 	 
	 	(b)	Number of shares of Common Stock to be registered pursuant to this Notice for resale:  

 

		4.	Broker-Dealer Status:

 

	 	(a)	Are you a broker-dealer? 

 

Yes ___            No___

 

	 	(b)	If “yes” to Section 4(a), did you receive your Registrable Securities as compensation for investment banking services to the Company? 

 

Yes ___            No___

 

    	B-2

    	 

    

 

	Note:  If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.  
	 
	 	(c)	Are you an affiliate of a broker-dealer? 

 

Yes ___            No___

 

	Note:  If yes, provide a narrative explanation below:  
	 
	 	(d)	If you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities? 

 

Yes ___            No___

 

	Note:  If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.  

 

		5.	Beneficial Ownership of Other Securities of the Company Owned by the Selling Shareholder.

 

Except as set forth below in
this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company other than the Registrable
Securities listed above in Item 3.

 

Type and amount of other securities
beneficially owned:

 

		6.	Relationships with the Company:

 

Except as set forth below, neither
the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity
securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or
its predecessors or affiliates) during the past three years.

 

State any exceptions here:

 

		7.	Plan of Distribution:

 

The undersigned has reviewed
the form of Plan of Distribution attached as Annex A to the Registration Rights Agreement, and hereby confirms that, except as
set forth below, the information contained therein regarding the undersigned and its plan of distribution is correct and complete.

 

State any exceptions here:

 

***********

    	B-3

    	 

    

  

By signing below, the
undersigned consents to the disclosure of the information contained herein in its answers to Items (1) through (7) above and the
inclusion of such information in the Resale Registration Statement and the Prospectus. The undersigned understands that such information
will be relied upon by the Company in connection with the preparation or amendment of any such Registration Statement and the Prospectus.

 

By signing below, the
undersigned acknowledges that it understands its obligation to comply, and agrees that it will comply, with the provisions of the
Exchange Act and the rules and regulations thereunder, particularly Regulation M in connection with any offering of Registrable
Securities pursuant to the Resale Registration Statement. The undersigned also acknowledges that it understands that the answers
to this Questionnaire are furnished for use in connection with Registration Statements filed pursuant to the Registration Rights
Agreement and any amendments or supplements thereto filed with the Commission pursuant to the Securities Act.

 

I confirm that, to
the best of my knowledge and belief, the foregoing statements (including, without limitation, the answers to this Questionnaire)
are correct.

 

IN WITNESS WHEREOF
the undersigned, by authority duly given, has caused this Questionnaire to be executed and delivered either in person or by its
duly authorized agent.

 

	Dated:	 	 	Beneficial Owner:	 

 

	 	 	 	By:	 
	 	 	 	 	 
	 	 	 	Name:	 
	 	 	 	 	 
	 	 	 	Title:	 

 

    	B-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]